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CHAPTER I 
 
INTRODUCTION 
The quest for a single novel idea that may somehow shape the way future generations relate 
to the diseases that plague the human race is a noble one. However, it has been seen time and again 
that nature has a way of creating therapeutics so robust and efficacious that they easily outstrip 
most synthetic medical remedies1. Unfortunately, many of the most effective synthetic and natural 
product molecules are exceedingly hydrophobic2-5. The underlying issue which prevents these 
cures from being readily utilized today lies in the inherent desire of the human immune system to 
destroy any entity deemed foreign to the body. This simple fact, which has evolved as a defense 
mechanism against disease, can wreak havoc on the therapeutics which have been found 
advantageous as remedies for many serious ailments that attack one’s health. Whether this 
limitation arises from the rapid removal of the therapeutics, or an inability to remain in solution in 
physiological conditions, the solution is the same: alternative methods of delivery must be created.  
Though methods have been developed to overcome these shortcomings, none has come so 
far as the field of polymer science, which continues to diversify into many fields of research from 
materials and packaging6 to drug delivery2-4, 7-29 and protein therapeutic formation18, 30-36. 
Throughout the years, numerous polymerization methods have been developed capable of utilizing 
an increasingly broad range of monomers to impart moieties of desired functionality to the 
synthesized polymer products. From these libraries of polymer possibilities, an ever expanding list 
of uses can be formed, tailored for a range of desired purposes. These varied polymerization 
techniques, including reversible addition-fragmentation chain-transfer (RAFT), atom-transfer 
radical polymerization (ATRP), and ring-opening polymerization (ROP), afford a range of reaction 
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possibilities which allow researchers to tailor the characteristics and functionality of their polymer 
products for the desired applications. RAFT based systems afford polymers with high functionality 
potential but drastically low biodegradability due to the acrylate based backbone, an issue that also 
plagues polymers formed through ATRP pathways. Furthermore, many RAFT and ATRP 
reactions require the utilization of metal or organic based catalysts that must be kept in 
environments without air or water to ensure their continued viability and efficacy. Conversely, 
ROP, which is capable of turning almost any non-aromatic cyclic species into a polymer product, 
has been exploited with great success to form polymers with diverse backbones and functionalities. 
This mechanistic pathway is responsible for the formation of many polymers that are investigated 
for their drug delivery potential, such as poly(ester)s, one of the most studied drug delivery 
polymers, as well as poly(carbonate)s, which have gained more popularity in recent years due to 
their enzymatic degradability. Both of these polymer systems can be employed in the formation of 
drug delivery platforms, and researchers have shown these systems to be advantageous for the 
delivery of poorly soluble drug molecules. With the varied degradation profiles of these polymers, 
poly(ester)s experiencing hydrolytic degradation and poly(carbonate)s undergoing enzymatic 
degradation, delivery systems can be tailored based on the desired route of administration, while 
the ability to incorporate functionalized monomer species broadens the scope of potential 
applications. Unfortunately, as with RAFT and ATRP, the methods employed in the formation of 
these polymers often require the utilization of inert atmospheric environments, leading to 
prolonged preparation and reaction times. 
One system that has been developed to address these stringent reaction conditions is the 
use of tin octanoate, a metal based catalyst that is sufficiently resistant to atmospheric conditions, 
allowing for benchtop synthesis of polymers through ROP12, 16, 20, 37. However, tin octanoate 
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requires the use of high temperatures to ensure the best catalytic potential, which can be 
problematic for some monomer species, and adds a level of complexity to the overall reaction 
conditions. Tin triflate is another tin based catalyst that has been studied for its catalytic potential, 
though to a lesser degree than tin octanoate. Research with this triflate derivative shows the ability 
to perform ROP based processes at room temperature, or slightly elevated temperatures, with great 
success, yielding poly(ester) and poly(carbonate) systems with well controlled molecular and 
polydispersities5, 38. The systems formed from polymers synthesized with tin triflate as the catalyst 
have been employed as drug delivery platforms for hydrophobic drug molecules and show true 
promise as targeted drug delivery vehicles39. The ability to marry these two worlds in order to form 
poly(ester) and poly(carbonate) systems with well-defined structures, from reactions at or slightly 
above room temperature, is truly a significant research discovery. This advance can be exploited 
to form poly(ester) and poly(carbonate) building blocks that can be utilized in the formation of 
polymer based structures for varied applications. 
Polymer based nanoparticles are a well-established class of drug delivery systems with 
many researchers endeavoring to formulate synthesis routes that will afford the largest amount of 
cargo loading while maintaining linear release profiles. These two goals are of utmost importance 
as they allow for the least stressful doctor schedule and accurate dosage amounts. Many drug 
delivery platforms have been developed to address one or both of these goals, but few are able to 
successfully form nanoparticle species with viable drug delivery applications. However, there has 
been impressive work done utilizing poly(ester) species to form degradable nanoparticles capable 
of high drug loading and linear release of the encapsulated cargo. Furthermore, these systems have 
shown application for the delivery of highly hydrophobic drug molecules, a realm that is populated 
by many of the most efficacious therapeutics. While these systems have been successful, their 
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relative hydrophobicity necessitates the utilization of a PEG surfactant for increased solubility, 
and a similar system formed from more hydrophilic polymer structures has the potential to 
maintain the high loading and release profile while decreasing the need for the presence of this 
PEG species. 
Another field that has continued to increase its utilization of polymer structures is that of 
protein therapeutics. The utilization of proteins as therapeutics has been a continuous growth sector 
since its advent in the 1980s when the first crude protein-polymer conjugates were formed by 
covalently binding a poly(ethylene glycol) (PEG) polymer to the surface of proteins to test its 
effect on the blood life of the formed conjugates. This straightforward approach to the formation 
of bioconjugates yields proteins with large decreases in reactivity, but disproportionately higher 
levels of efficacy and decreased immunogenicity. This increase in therapeutic ability arises from 
the cloaking function the polymer structures perform, allowing the proteins to survive and circulate 
for longer periods in the body33, 36, 40, 41. Though PEG is still the most widely utilized polymer for 
the formation of these protein-polymer conjugates, with fourteen PEGylated species on the market, 
the prolonged administration necessary for the treatment of many of the diseases applicable for 
protein therapy has shown that large linear species can lead to polymer aggregation. For this 
reason, the use of branched PEG species has begun to be investigated, with results showing 
branched species of lower molecular weight are capable of yielding protein-polymer conjugates 
with the same, and in some cases improved, therapeutic activity. However, this method adds 
complexity to the polymerization reaction, as many of the branched species are accomplished 
through the secondary functionalization of other types of polymers, such as poly(acrylate)s30. 
Polymers can be chosen that lead to decreased immunogenicity as well as increased plasma half-
life, allowing the proteins to not only be more effective, but administered less often. Though not a 
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disqualifying factor, the ability to form polymers of similar architecture and shielding ability to 
PEG through a single step reaction mechanism would be an exciting advancement within the field 
of protein therapeutics. 
The field of hydrogel formation is one that, since its inception, has been dominated by 
polymers19, 22, 28, 42. The ability to form a hypercrosslinked network, affording a product that is 
insoluble and, dependent upon the polymer building blocks chosen, rigid, has led to the use of 
hydrogel structures in diverse fields from tissue scaffolds to drug delivery vehicles. Furthermore, 
the myriad of gelation reactions that are available for hydrogel formation have opened the field to 
almost every conceivable fabrication method, as gels of the desired size and morphology can be 
formed either before or after the gelation step, allowing researchers to work in both the solid and 
liquid phases during formulation. Not only does this allow for an enormous range of formation 
potential, it also affords researchers unparalleled creative license in the choice of polymer building 
blocks as well as the cargo that is to be delivered. The most studied polymer scaffold is formed 
from poly(lactic-glycolic acid), a hydrolytically degradable polymer that affords some degree of 
rigidity and a surface well suited for cell growth and tissue regeneration28, 29, 43, 44. However, the 
degradation of PLGA leads to localized acidity issues and the rigidity of the system limits the 
potential applications for systems formed from this polymer species29. The ability to form gel 
systems which can degrade into inert products and harness the linear release profiles seen with 
other gel systems is another exciting avenue for research. 
Dissertation Overview 
 Polymerization methods have been developed and characterized for the synthesis of 
numerous polymer products including poly(glycidol), poly(carbonate), and poly(ester) systems. 
These polymer building blocks were then employed in the formation of novel nano- and micro-
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polymer networks with the purpose of sustained drug delivery. Through the course of this work, 
tin triflate was used as a readily active catalyst capable of driving benchtop reactions with good 
control of polymer size and polydispersity. Furthermore, the nature of the research allowed 
alternate avenues for the polymerization and utilization of poly(glycidol) to be pursued. 
 Using tin triflate, poly(glycidol) structures with hitherto unseen degrees of branching were 
formed. The control over this branching was seen achieved through depression or increase of the 
reaction temperature, with reaction temperature having a direct relationship with polymer 
branching. Functionalized glycidol monomers were easily incorporated into the growing polymer 
structures through the same polymerization methods and afforded systems with further decrease 
in overall polymer branching. By exploiting the inherent interaction between glycidol and water a 
secondary reaction pathway was discovered in which poly(glycidol) systems were formed in the 
presence of slightly acidic phosphate buffer solution. In order to fully understand this novel 
pathway a number of parameters, including pH, concentration, and reaction temperature were 
investigated. It was also discovered that functionalized monomer units could be successfully 
incorporated into the system though to a slightly lesser degree than with the tin systems. Most 
importantly, this new method yielded products with even lower branching and represents an 
entirely new polymerization technique called aqueous epoxide ring-opening polymerization 
(AEROP). 
 Taking what was learned from the discovery of AEROP, in conjunction with the fact that 
poly(glycidol) very nearly mirrors the structure of PEG, research focused on the implementation 
of poly(glycidol) as a cloaking polymer for the formation of protein-polymer conjugates. Through 
a graft-from method in water, protein-polymer conjugates of bovine serum albumin (BSA) and 
lysozyme (LYZ) were successfully formed and characterized. Furthermore, through the 
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adjustment of reaction time and concentration, polymer species of increased length were 
successfully attached to the protein surfaces. These proteins were investigated for their retained 
bioactivity and proved comparable to PEG counterparts. 
 Using the synthesized, allyl-functionalized poly(glycidol)s, and, separately, allyl-
functionalized poly(ester)s, nanonetwork structures were successfully formed through thiolene-
click reactions with 3,6-dioxa-1,8-octanedithiol to form nanoparticles with distinctly variable 
hydrophilicity. Particle crosslinking was varied through this thiolene-click reaction to yield 
products with variable crosslinking density, which will allow for control over the release rate of 
the cargo that will be loaded. These systems stand poised to be employed as drug delivery vehicles 
that, with their diverse chemical characteristics, can be utilized for a broad range of potential 
therapeutic cargo. 
 Thiolene-click chemistry was also employed in the formation hydrogel systems through 
the use of highly concentrated conditions. 3,6-dioxa-1,8-octanedithiol was used to covalently 
attach allyl poly(carbonate) and/or allyl poly(glycidol) polymer species together with sufficiently 
high crosslinking to yield insoluble hydrogel structures with varied chemical and structural 
properties. These gel structures were first formed on the macroscale before utilizing the gel 
solution as an ink that was printed, using a piezoelectric printing cartridge, to give micron size 
hydrogel structures loaded with dye molecules which served as fluorescent drug cargo. Through 
this method, microparticles of 2-15µm were successfully fabricated in a highly reproducible and 
monodisperse manner. 
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CHAPTER II 
 
SYNTHESIS OF POLY(GLYCIDOL) WITH TAILORED BRANCHING AND 
FUNCTIONALITY 
Introduction 
The emergence of poly(ethylene glycol) (PEG) as a highly versatile and biocompatible 
polymer system has afforded some of the most profound advances in such diverse fields as drug 
delivery1-3, protein therapeutics4-6, diagnostic development7, and even food and hygiene additives8. 
As the years progressed, it was shown time and again that branched PEG structures, when 
compared to the historically utilized linear species, were capable of achieving greater results with 
lower molecular weights, eliminating waste and leading to more stable systems. While numerous 
methods are available for the formation of these branched PEG species, there is no direct synthesis 
route that will afford the desired branched species in a one-step reaction. Thus, the door has been 
left open for the discovery of a synthesis route capable of preparing branched polymers with 
similar capabilities while maintaining the advantageous characteristics of PEG. 
Glycidol is an interesting monomer, consisting of an epoxide ring with a pendant 
hydroxymethyl group. The monomer can readily undergo polymerization through a number of 
pathways, both anionic and cationic, to yield polymer species with hyperbranched, dendrimer like 
architectures or, with the use of protected monomer species, polymers that are completely linear9-
26. Hitherto, research has focused on these two extremes, or on systems where linear species are 
tethered to hyperbranched structures27. However, little attention has been paid to the intermediate 
area where neither linearity nor branching dominates. For this reason, we endeavored to formulate 
polymerization reactions capable of studying this broad region of unknown potential. 
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 The formation of single-step dendrimer like macromolecules that provide the abilities of 
dendrimers without the painstaking process of dendrimer growth have garnered the most attention 
from those interested in the formation of poly(glycidol). The latent AB2 monomer characteristic 
of glycidol allows for additional control through a step-wise polymerization rather than a rampant 
polycondensation, which is the usual reaction mechanism seen with other AB2 type monomers 
(See Figure II-1). The capability of the glycidol monomer to suppress this AB2 characteristic until 
after the ring opens has contributed to the success of glycidol based polymers. This added control 
allows the synthesized poly(glycidol)s to maintain the benefits of other hyperbranched systems 
while affording macromolecules with polydispersity indices (PDIs) of 1.5 and lower, much more 
manageable than the PDIs of 5 or greater observed with other AB2 type monomers
10, 11, 14, 15, 22. 
Work in this field has been successful in forming hyperbranched poly(glycidol) systems, in 
varying sizes, with low polydispersity indices (PDIs) and controlled degrees of polymerization 
 
Figure II-1: Ring opening possibilities for the formation of poly(glycidol) 
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(DP). These systems could very well become advantageous as alternatives to multistep dendrimer 
species.  
The polymer systems that have been formed from these methods have found use in numerous 
applications ranging from potential vaccine models and selective drug delivery vehicles to 
biomineralization control and soluble catalyst supports in organic synthesis12, 28-30. Much of the 
success seen in these applications arises from the inherent characteristics of the poly(glycidol)’s 
branched structure. Conversely, limiting the degree of branching (DB), if possible with little 
change to the PDI, could prove beneficial in the formation of new, and possibly more robust, 
poly(glycidol) architectures24.  
The current methods for the formation of completely linear poly(glycidol)s rely on the use of 
protected glycidol derivatives polymerized under stringent anionic polymerization conditions. The 
protected polymers must then be subjected to a deprotection step that removes the protecting 
group, leaving a linear poly(glycidol) structure. This is a highly effective method for the formation 
of linear poly(glycidol) species; however, this synthetic route is far from what one might consider 
a facile synthesis method26, 27, 31, 32.  
The utilization of glycidol based polymers presents many advantages over the previously 
utilized PEG system. The preferential branching of poly(glycidol) during the polymerization 
process affords a final structure similar to the branched PEG species which must be formed through 
a multistep synthesis process. Furthermore, the backbone of the poly(glycidol) structures exhibits 
a high degree of similarity to PEG with repeating ether units, similar to polyethylene oxide and 
polyvinyl alcohol that, along with the pendant hydroxyls, add to the extreme hydrophilicity of the 
polymers22, 26, 27, 31-33.  
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The research described herein is aimed at combating the problems associated with GLY based 
polymers, while still maintaining a high degree of water solubility and low PDI values24. Research 
focused on the inclusion of increased physiological degradability, through the incorporation of 
esters, as well as the introduction of more viable post modification units, such as thiols and allyl 
groups. Furthermore, two distinct polymerization methods will be discussed. The first involves 
stannous triflate, which has been chosen as the desired catalysis method based on its ability to 
allow for low reaction temperatures while maintaining high polymerization rates and low PDI 
values. The second method involves a newly formulated catalysis method that harnesses the 
glycidol monomer’s known homopolymerization in water by introducing slightly acidic phosphate 
buffer to the glycidol monomer9. The chemical characteristics of the synthesized polymers will be 
investigated through both 1HNMR and 13CNMR techniques, while the biological conjugates will 
be characterized using a number of other techniques. By employing the stannous triflate catalyst 
at low temperatures, the DB of the resulting polymers can be restricted to well below the currently 
published values of 0.56 and higher12, 22. The ability of comonomers to copolymerize with glycidol 
to form an array of new and exciting polymer architectures, is also discussed. These polymers are 
proving to have interesting structural features and will foster in a new regime of polymers with 
high functionality, solubility and tunable biodegradability, thus imbuing all the benefits of 
poly(glycidol) based structures to systems that are more tailored for delivery of a range of cargo. 
Once these systems have been formed they will be utilized for the purposes of protein-polymer 
conjugate formation, and the development of precise polymer networks on the nano and micron 
scale for delivery of therapeutics. 
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Results and Discussion 
Development of a Novel Benchtop Polymerization Synthesis of Poly(glycidol) 
Poly(glycidol) has long been studied for its interesting characteristics and relative ease of 
secondary functionalization. The latent AB2 type monomer gives rise to one-pot reactions yielding 
hyperbranched, dendrimer-like structures, in a much faster and more facile manner12-16, 18, 22. 
Furthermore, the utilization of protected monomer units can give rise, after subsequent 
deprotection, to completely linear structures that can be post modified via hydroxyl based 
modification reactions13, 23, 25. Unfortunately, the synthesis methods utilized thus far have major 
pitfalls for those looking for a facile synthesis route. For these reasons, a synthesis method was 
sought that would facilitate the formation of poly(glycidol) based structures of tunable branching 
characteristic through reaction mechanisms capable of yielding products in a benchtop synthesis. 
 The use of stannous triflate (Sn(OTf)2) as a benchtop ring opening polymerization catalyst 
has been studied previously in the lab for the formation of poly(ester) based polymer systems as 
building blocks for nanoparticle structures. In this work, allyl functionalized monomers are used 
to form random copolymers with pendant allyl groups. These groups are then oxidized to epoxides 
for use in amine-epoxide crosslinking reactions. It was observed that, after epoxidation, the 
presence of Sn(OTf)2 would facilitate a rapid ring opening of the newly formed epoxide, rendering 
them unviable as crosslinking units. It was therefore hypothesized that Sn(OTf)2 could be used as 
a catalyst for the ring opening polymerization of glycidol to form poly(glycidol) based structures 
in a benchtop synthesis.  
Determination of Kinetic Control over Degree of Branching 
 Initial polymerizations were performed using glycidol as the only monomer unit. Work has 
been done suggesting that the opening of epoxide rings can be controlled kinetically10, and so a 
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kinetic study was performed to fully investigate the extent of this control. For the study four   
Figure II-3: 13C-NMR showing decrease in dendritic character with decreasing temperature 
 
L1,3 D 2L1,4 T1 
40°C 
20°C 
0°C 
-20°C 
Region Shift (ppm) 40°C 20°C 0°C -20°C 
L1,3 81.0-82.0 1.00 1.00 1.00 1.00 
D 79.5-80.5 
0.79 0.62 0.60 0.48 
2 L1,4 73.5-74.5 3.69 3.65 3.98 4.80 
2D, 2T 72.0-73.5 
7.05 7.52 7.62 8.44 
L1,3, L1,4 70.5-72.0 3.14 3.01 3.17 2.93 
T 64.0-65.0 
1.74 2.13 2.17 3.53 
L1,3 62.0-63.5 3.15 2.97 2.76 2.87 
Degree of Branching 
0.24 0.21 0.20 0.15 
Relative Abundance of 
Dendritic Carbons 
10.5% 8.2% 8.0% 5.2 
Figure II-2: Degree of branching and relative abundance of dendritic carbons for the four 
chosen temperatures for polymerization with Sn(OTf)2 
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kinetic study was performed to fully investigate the extent of this control. For the study four 
temperatures were chosen; -20°C, 0°C, 20°C, and 40°C (See Figure II-3). In order to maintain 
constant reaction temperatures, a solvent circulator was employed along with specialized 
glassware that allowed a constant flow of temperature stabilized solution to completely surround 
the polymerization reaction vessel. The Sn(OTf)2 catalyst and isoamyl alcohol initiator were added 
to the flask and allowed to stir for 30 minutes to facilitate alcohol catalyst conjugation. The 
glycidol monomer was then added dropwise via syringe and the reaction was allowed to run until 
stirring was fully impeded. As expected, reaction times were inversely correlated to reaction 
temperature, and, interestingly, the degree of branching observed for each reaction varied directly 
with temperature, showing that the catalyzed reactions were in fact influenced by the temperature 
of the reaction. This exciting point yielded polymers with branching lower than that seen 
previously in the literature (See Figure II-2), thus allowing for a new classification of 
semibranched poly(glycidol). 
The Formation of Stretchable Gas Barriers 
 In order to test the versatility of the newly synthesized poly(glycidol) systems, we worked 
with the Grunlan lab at Texas A&M to incorporate the poly(glycidol) into their work towards the 
formation of better, more flexible gas barriers. Using a Layer-by-Layer (LbL) deposition 
technique, the lab created tri-layers of polyethylenimine (PEI), montmorillonite (MMT) clay, and 
poly(glycidol). The newly formed coatings were tested for their oxygen barrier ability before and 
after a 10% stretching was performed, and it was determined that the barriers containing 
poly(glycidol) had a 17% barrier loss after stretching. However, those films without poly(glycidol) 
experienced a barrier loss of 4350%. This was an astonishing difference and represents the first 
reported stretchable thin film gas barrier. Furthermore, this proof of concept investigation points 
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to these poly(glycidol) containing thin films as method for the production of pressurized elastomer 
systems, stretchable electronic applications, or even food packaging34. 
Introduction of Comonomers for Added Functionality 
 The discovery of this method was substantial, but to fully exploit the synthesis the 
formation of functionalized poly(glycidol) structures was desired. For this reason allyl glycidyl 
ether (AGE), a readily available glycidol derivative, was chosen to impart allyl functionality into 
the polymer backbone (See Figure II-4). Although not quite as reactive as the glycidol, by using 
Sn(OTf)2 as a catalyst, AGE was easily incorporated into the backbone of the polymer at varying 
percentages. These reactions were run at room temperature following a similar procedure as the 
glycidol homopolymer. After the catalyst and initiator were complexed, the AGE was added 
dropwise followed by the dropwise addition of the glycidol monomer. Reactions were complete 
after 24 hours and after purification it was determined that the allyl monomer was successfully 
incorporated. The significance of this was twofold. The polymer formed was more readily capable 
of secondary modification, through the incorporation of another reactive unit, and the fact that 
AGE is an AB and not AB2 type monomer led to species with still lower degrees of branching 
affording a second parameter that can be exploited for the formation of semibranched structures. 
Advent of Green Synthesis Methods 
Although the newly discovered polymerization proved to be very advantageous, there is a 
characteristic of glycidol that can still be exploited. It has been reported that in the presence of 
 
Figure II-4: Synthesis of poly(glycidol-co-allyl glycidyl ether) with Sn(OTf)2 
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water glycidol can undergo an autopolymerization, yielding short species of no real utility9. 
However, it was hypothesized that this inherent ability could be exploited, under the right 
conditions, to form both homopolymers, as well as functionalized copolymers, to be used in 
subsequent research goals. Previous work has shown that thermal cracking of the glycidol epoxide, 
in the presence of a weak nucleophile, can lead to ring opening of either the substituted or 
unsubstituted side, thus affording another parameter that can be investigated to determine the best 
manner conditions for this novel polymerization route9. 
Optimization of Reaction Conditions 
In order to fully investigate this intriguing idea, three reaction temperatures were chosen, 
60°C, 80°C, and 100°C (See Figure II-5), with unique reaction times for each temperature (5 days, 
3 days, and 1 day respectively). For the purpose of initiation of the homopolymerization reaction, 
it was decided that slightly acidic phosphate buffer (pH 6.0) would be added to the stirring 
Region Shift (ppm) 60°C (13.5M) 80°C (13.5M) 100°C (13.5M) 
L1,3 81.0-82.0 1 1 1 
D 79.5-80.5 1.5017 1.2115 1.2699 
2 L1,4 73.5-74.5 12.483 11.7599 10.6349 
2D, 2T 72.0-73.5 9.5734 9.7469 10.154 
L1,3, L1,4 70.5-72.0 6.6037 6.1915 5.6924 
T 64.0-65.0 3.274 3.4851 3.6807 
L1,3 62.0-63.5 1.1331 1.2588 1.4066 
Degree of Branching 0.29 0.25 0.27 
Percent Yield 2.7 31.8 37.1 
Figure II-5: Green polymer synthesis temperature studies 
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monomers prior to  that slightly acidic                              (pH 6.0) would be added to the stirring 
Region Shift (ppm) 
2x GLY 
(14.3M) 
3x GLY 
(14.5M) 
2x PB 
(12.3M) 
3x PB 
(11.2M) 
4x PB 
(10.4M) 
L1,3 81.0-82.0 1 1 1 1 1 
D 79.5-80.5 1.2789 1.1456 1.2074 0.8681 0.8332 
2 L1,4 73.5-74.5 10.9784 11.577 11.7041 12.1723 12.7717 
2D, 2T 72.0-73.5 8.8949 9.758 9.3083 9.6674 9.8932 
L1,3, L1,4 70.5-72.0 5.7718 5.8661 5.9154 5.2936 5.3063 
T 64.0-65.0 3.0503 3.7491 3.4265 5.081 5.4274 
L1,3 62.0-63.5 1.1353 1.0645 1.0847 1.2939 1.3443 
Degree of Branching 0.28 0.25 0.26 0.19 0.18 
Percent Yield 49.6 65.0 46.6 48.9 29.1 
Figure II-6: Green polymer synthesis concentration studies 
Region Shift (ppm) 
pH=3.75 
(13.5M) 
pH= 6.00 
(13.5M) 
pH=7.99 
(13.5M) 
DI Water 
(13.5M) 
L1,3 81.0-82.0 1 1 1 1 
D 79.5-80.5 1.2285 1.2115 1.2447 1.0542 
2 L1,4 73.5-74.5 10.4149 11.7599 10.7286 11.2358 
2D, 2T 72.0-73.5 8.8071 9.7469 8.9013 8.346 
L1,3, L1,4 70.5-72.0 5.4975 6.1915 5.6529 5.4162 
T 64.0-65.0 2.9902 3.4851 2.9783 3.5474 
L1,3 62.0-63.5 1.2266 1.2588 1.2039 1.4076 
Degree of Branching 0.28 0.25 0.27 0.23 
Percent Yield 31.9 31.8 24.5 1.2 
Figure II-7: Green polymer synthesis pH studies 
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monomers prior to submersion in the oil baths, as it was believed that the slight acidity would 
elevate the potential for homopolymerization All three reaction temperatures yielded polymer 
products, but the lowest branching product was achieved at 80°C, and so this temperature was 
chosen for studies that investigated the effects of monomer concentration and pH on the polymer 
products formed. It was seen that the manipulation of these three parameters yielded products that 
were similar in size but somewhat different in degree of branching and relative abundance of the 
numerous glycidol repeat units.  
The first parameter that was studied was monomer concentration, which was varied by 
either increasing the amount of glycidol present or the amount of PB used (See Figure II-6 and 
Figure II-8). Interestingly, it was seen that as the concentration was increased through the addition 
of more monomer, as well as when the concentration was decreased by the use of more PB, there 
was a decrease in the DB observed for the polymer products, with very low branching of below 
0.20 seen for the low concentration reactions. However, the low concentration reactions saw a 
marked decrease in yield proportional to the decrease in concentration while the yield for the 
higher concentration reactions was increased. The real difference was seen in the relative 
Unit 2x GLY 
(14.3M) 
3x GLY 
(14.5M) 
2x PB 
(12.3M) 
3x PB 
(11.2M) 
4x PB 
(10.4M) 
Terminal 28 32 30 38 39 
Linear 1,3 10 9 9 10 10 
Linear 1,4 50 49 51 45 45 
Dendritic 12 10 10 7 6 
Figure II-8: Green polymer synthesis: relative abundance of repeat units from concentration 
studies 
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abundance of repeat units, with the lower concentration polymers exhibiting increased amounts of 
terminal units and decreased amounts of branched units, pointing toward polymers of shorter size. 
 The final parameter that was studied was the pH of the PB used to catalyze the 
polymerizations (See Figure II-7). This was an interesting study as it was determined that an 
increase or decrease in pH led to polymers of higher DB. Furthermore, by running a reaction in DI 
water it was seen that little polymerization was possible, further alluding to the fact that some 
acidity or basicity is necessary to truly drive the autopolymerization process and yield polymers 
of viable length, capable of undergoing the precipitation process for purification. 
Determination of Green Polymer Molecular Weight  
 The ability to form polymers in this novel green method was exciting, and the low degrees 
of branching meant that, once again, a new class of poly(glycidol) structures had been formed. As 
such, thorough investigation of the size of the synthesized polymers was desired. The first 
characterization method used was gel permeation chromatography and the results were intriguing. 
Historically, it has been difficult to characterize the size of branched structures due to their 
inherently high PDI values of 1.5 and higher, which arises from the low degree of control over the 
polymerization method due to multiple possible initiation points. However, the new systems 
showed good polymer control with PDIs of 1.2 and lower. This low PDI meant that the sizes of 
the polymers could be directly determined using MALDI-TOF-MS measurements, which was 
accomplished by spotting the polymers with a dithranol matrix. The data resulting from this 
investigation showed that the polymers formed from this new method were around 1500-1000 Da 
and that the concentration of the reactions is able to shift the polymer size obtained (See Figure II-
9).  
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 Introduction of Comonomers for Added Functionality 
In the case of copolymers with AGE, we were successful in incorporating the allyl 
monomer but to a lower degree as was seen in the metal catalyzed system, a fact explained by the 
exaggerated difference in the reaction rate of glycidol and AGE (See Figure II-10). For these 
reactions, a similar strategy was developed whereby both monomer units were added to the dry 
reaction vessel followed by the addition of PB prior to submersion into the oil bath at 80°C. To 
Figure II-9: GPC and MALDI data for polymers formed with varying concentration 
T1 
T1 
L1,4 
L1,3 
D 
D 
 
Figure II-10: Green synthesis of poly(glycidol-co-allyl glycidyl ether)  
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combat the lower than desired incorporation of AGE into the growing polymer chain, due to the 
reaction mechanism, a range of molar equivalences were chosen to study the capability of this 
technique to impart substantial allyl functionality into the system. The three reactions performed 
utilized GLY:AGE ratios of 1:1, 3:2, and 7:3, with the allyl incorporation seen to be 8.6%, 7.5%, 
and 5.6% respectively. Furthermore, in order to obtain even higher incorporation, and taking into 
consideration the slower reaction rate of AGE, another reaction with 1:1 molar equivalences was 
allowed to run for 5 days rather than the 3 days used in the original reactions. These reaction 
conditions afforded a polymer with 11.7% allyl incorporation. This set of experiments 
demonstrates the utility of this new method as a route for the formation of functionalized 
poly(glycidol) systems. 
Comparison of Novel Polymerization Methods 
 
Figure II-11: Metal based polymer vs. the newly synthesized green polymer system 
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 The ability to exploit the glycidol monomers inherent reaction in the presence of water was 
a very exciting discovery that led to the first reported synthesis of useful poly(glycidol) based 
polymers through a completely green synthesis method. However, we were very interested to 
determine the differences between the tin based synthesis and the green method. For this 
investigation we chose to use inverse gated quantitative NMR (See Figure II-11). It has been shown 
that this technique can be used to directly calculate both the degree of branching within the polymer 
species as well as the relative abundance of each type of repeat unit. The exhaustive 
characterization of these new systems showed a distinctly different backbone for each of the 
polymer synthesis routes. The difference between the two systems was visually apparent upon 
performing the NMR measurements, with the green synthesis polymer exhibiting a much simpler 
NMR spectra, pointing to a polymer with fewer distinct ring opening possibilities. Without the 
presence of the tin, no T2 termination units were observed, a fact that points to exclusive ring 
opening from the unsubstituted side of the glycidol ring in the green synthesis method. This 
intriguing fact is further accentuated when comparing the relative abundances of the different 
repeat units in the polymers where it was calculated that the green synthesis polymer contained 
50% L1,4 characteristic, almost twice that seen in the tin-based polymer (See Figure II-12). This 
Reaction 
Conditions 
T L 1,3 L 1,4 D 
80°C 29 11 50 10 
Metal  24 32 26 18 
Figure II-12: Difference in relative abundance of repeat units between green synthesis and 
tin based system  
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repeat unit is the dominating unit for the production of more linear species and explains why the 
green synthesis polymers have such a reduced degree of branching from the tin-based system. 
The Elucidation of a Unique Polymerization Mechanism 
 Now that we knew the green synthesis products were unique and new to the field of 
poly(glycidol) structures, we were interested in determining how these structures were formed, 
and for this a new mechanism was necessary. The two known mechanisms for glycidol are the 
activated chain end (ACE), which we can rule out as this method gives large amounts of L1,3 
characteristic, and activated monomer mechanism (AM), which is most likely the prevailing 
mechanism in our case since the acidic pH buffer affords the ability to protonate the epoxide 
oxygen. However, the AM mechanism usually requires the presence of an activated oxoanion for 
sufficient nucleophilic attack. This issue is overcome in our reaction due to the elevated reaction 
 
Figure II-13: New mechanism for the green synthesis method 
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temperature, which allows not only the glycidol monomer to attack another monomer unit, but 
also the hydroxyls on the growing polymer chain, as well as water, which was determined from 
the obtained MALDI data. This unique convergence of thermal activation, with the activated 
monomer mechanism, leads to a mechanism with sole attack at the unsubstituted side of the 
monomer unit (See Figure II-13). This argument is made since attack at the substituted side of the 
glycidol ring could potentially yield a T2 termination, which is not seen in the NMR data. Together, 
these arguments answer all of the structural anomalies seen in this novel polymer system and allow 
us to propose a new type of polymerization mechanism named Aqueous Epoxide Ring Opening 
Polymerization (AEROP). This mechanism combines the classic AM mechanism with elevated 
temperature and slight acidity to facilitate a facile yet controlled polymerization yielding well 
controlled poly(glycidol) structures. 
Conclusion 
 The polymerization techniques described here represent two novel synthesis routes for the 
formation of poly(glycidol) based structures with reduced degrees of branching. The utilization of 
tin triflate as a benchtop catalyst gives control over the polymerization process while simplifying 
the reaction conditions and reducing reaction time relative to previously published polymerization 
techniques. The newly developed green synthesis method is the first reported example of a green 
synthesis route capable of forming poly(glycidol) structures of real utility. Furthermore, both 
methods are capable of yielding functionalized polymer products that can be employed for the 
formation of novel nano- and micronscale polymer architectures. 
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Experimental 
Materials 
All reaction solvents used were HPLC quality and purchased from Sigma Aldrich. All 
NMR solvents were purchased from Cambridge Isotope Laboratories, Inc. and used without 
further purification. Allyl glycidyl ether (AGE), ≥99%, sodium hydroxide, ≥97%, and 
dithranol, ≥98%, was purchased from Sigma Aldrich and used without further purification. 
Hydrochloric acid, 11.65M, was purchased from EMD and used without further 
purification. Glycidol (GLY), 96%, was purchased from Sigma Aldrich and vacuum 
distilled prior to use with a Kugelrohr short-path distillation device. Dulbecco’s Phosphate 
Buffered Saline (PBS), no calcium, no magnesium, was purchased from life technologies 
and the pH was attenuated using either sodium hydroxide or hydrochloric acid prior to use. 
Characterization 
1H and 13C NMR spectroscopy was performed using a Bruker 600 spectrometer operating at 600 
and 150 MHz, respectively. The instrument is equipped with a 14.1 Tesla Bruker magnet, which 
is controlled by a Bruker AV-II console, and a 5mm Z-gradient TCI Cryo-probe. A 20 second 
recycle delay was used to insure full relaxation for quantitative measurements, which allowed for 
the elucidation of specific monomer unit peaks and subsequent calculation of the degree of 
branching present in each glycidol homopolymer. MALDI measurements were accomplished 
using a Voyager DE-STR MS in linear TOF mode equipped with a nitrogen gas laser at λ= 337nm 
with external calibration. The individual instrument parameters varied based on the samples being 
characterized. Size exclusion measurements were obtained with a Waters chromatograph system 
equipped with a Waters 2414 refractive index detector, a Waters 1525 binary HPLC pump, and 
four 5 mm Waters columns (300 mm x 7.7 mm), connected in series with increasing pore size 
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(100, 1000, 100,000 and 1,000,000 Ǻ respectively). All runs were performed with N-N-
dimethylformamide (DMF) as the eluent at a flow rate of 1 mL/min.  
General Procedure for GLY based polymers 
In order to maintain a consistent temperature throughout the entirety of the polymerization, a 
specialized round bottom flask and cooling system were employed. The round bottom flask was 
formed with a 25mL reaction vessel enveloped by a glass “jacket” with an inlet at the bottom and 
an outlet at the top. This allowed for a temperature controlled liquid to constantly surround the 
reaction vessel, thus allowing for sustained reaction temperature. The pump system used was a 7 
Liter Refrigerated Circulator obtained from PolyScience with a temperature range of -40°C to 
200°C and a temperature stability of ±0.01°C.   
Two 1-dram vials were fitted with septa and flame dried under N2(g). The first 1-dram vial was 
used to make a 1.7M Iso-Amyl alcohol (IAOH) stock solution using dry THF, while the second 
was used to create a 3.7x10-2M tin triflate stock solution, also using dry THF. Stock IAOH 
(0.20mL, 3.33x10-4 mol, 0.066eq) and Sn(OTf)2 (0.26mL, 9.45x10
-6 mol, 0.00035 eq) were added 
to the jacketed reaction flask, equipped with a magnetic stir bar, at the chosen reaction temperature, 
and the reaction solution was allowed to stir for 30 minutes to allow for the alcohol/catalyst 
conjugation. The reaction flask was then brought to the proper reaction temperature before addition 
of the monomers and the polymerization was allowed to run to completion.  
CAUTION: When the scale of the reaction is above 1g, the reaction can become very exothermic 
during monomer addition and dropwise monomer addition is required in order to deter 
decomposition.  
 
 
 34 
 
Synthesis of GLY Homopolymer 
To the jacketed reaction flask equilibrated to the desired temperature was added Sn(OTf)2 
(0.26mL; 9.45x10-6 mol; 0.00035 eq) and EtOH (0.20mL; 3.33x10-4 mol; 0.066 eq). After the 
complexation of the initiator to the catalyst, glycidol (2.00g; 27.0 mmol; 1.0 eq) was added 
dropwise. After stirring was completely impeded (reaction time varied with temperature), the 
crude viscous polymer product was dissolved in a minimal amount of methanol and precipitated 
into vigorously stirring acetone, which was then decanted to afford the pure glycidol homopolymer 
product as translucent viscous material. The product was collected in methanol, transferred to a 
weighed 6-dram vial, and the excess solvent was removed. Yield: 1.89g (94.8%) 1H-NMR 
(600MHz, CDCl3) δ: 3.31-3.94 (6H). 13C-NMR (150MHz, CDCl3) δ: 81.37, 79.81, 75.12, 73.88, 
72.01-72.94, 70.42-71.17, 64.41, 62.53, 62.06.  
Synthesis of GLY/AGE Polymer (80/20) 
Sn(OTf)2 (0.23mL; 8.52x10
-6 mol; 0.00035 eq) and EtOH (0.196mL; 3.33x10-4 mol; 0.066 eq) 
were added to the reaction flask. After the complexation of the initiator to the catalyst, the glycidol 
(1.44g; 19.47 mmol; 4.0 eq) and allyl glycidyl ether (0.56g; 4.87 mmol; 1.0 eq) were added 
dropwise. After stirring was completely impeded (reaction time varied with temperature), the 
crude viscous polymer product was dissolved in a minimal amount of methanol and precipitated 
into vigorously stirring acetone, which was then decanted to afford the pure GLY/AGE polymer 
product as translucent viscous material. The product was collected in methanol, transferred to a 
weighed 6-dram vial, and the excess solvent was removed.  Yield: 1.23g (68.3%). 1H-NMR 
(600MHz, CDCl3) δ: 5.92 (1H), 5.21 (2H), 4.04 (2H), 3.38-3.94 (27.30H). 13C-NMR (150MHz, 
CDCl3) δ: 136.31, 117.42, 81.56, 80.01, 74.09, 73.43, 72.51, 70.87, 64.60, 62.69. 
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Synthesis of GLY Homopolymer in Phosphate Buffer  
To prepare the GLY homopolymers, glycidol monomer (33mmol, 1.0eq) was added to a flame 
dried 25mL round bottom flask (RBF). The reaction vessels were then lowered into oil baths of 
varying temperature (60°C, 80°C, or 100°C) to ensure consistent reaction temperatures, followed 
by the addition of DPBS (0.25mL; pH= 6.0). After a predetermined reaction time based on the 
reaction temperature (120h, 72h, and 24h  respectively), the crude viscous polymer product was 
dissolved in a minimal amount of methanol and precipitated into vigorously stirring acetone. The 
resulting solution was decanted to afford the pure GLY product as a translucent viscous material. 
The product was collected in methanol, transferred to a weighed 6-dram vial, and the excess 
solvent was removed. Once it had been determined that the reaction at 80°C yielded the product 
with the most desirable DB, other reaction conditions were altered at this temperature, including 
reaction concentration and the pH of DPBS used. 1H-NMR (600MHz, CDCl3) δ: 3.42-3.87 (6H). 
13C-NMR (150MHz, CDCl3) δ: 81.33, 79.75 73.84, 72.36, 70.90, 70.62, 64.32, 62.71 
Synthesis of GLY/AGE Copolymer in Phosphate Buffer  
To prepare GLY/AGE copolymers, glycidol monomer (17.5mmol, 2.3 eq,) was added to a flame 
dried 25mL RBF equipped with a stir bar. The allyl glycidyl ether monomer (7.5mmol, 1.0 eq) 
was then added via syringe and the reaction vessel was lowered into an oil bath at 80̊C before the 
addition of DPBS (0.25mL; pH= 6.0). The reaction was then allowed to run for 72 hours before 
being removed from the oil bath, dissolved in a minimal amount of methanol and precipitated into 
vigorously stirring ethyl acetate. After allowing the solution to settle, the supernatant was decanted 
and the resulting polymer product was collected in methanol, transferred to a weighed 6-dram vial, 
and dried on the pump to remove all solvent. In order to determine the amount of allyl characteristic 
that could be incorporated into the final copolymer product, a molar equivalent ratio of GLY:AGE 
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of 1:1 was used in a subsequent reaction. 1H-NMR (600MHz, CDCl3) δ:6.0-5.90  (m, –
OCH2CHCH2), 5.37–5.17 (m, –OCH2CHCH2) .3.97-3.42 (6H). 13C-NMR (150MHz, CDCl3) δ: 
136.31, 117.39, 81.37, 79.81, 75.12, 73.88, 72.01-72.94, 70.42-71.17, 64.41, 62.53, 62.06, 27.99, 
27.60.  
Quantitative NMR Measurements  
1H and 13C NMR spectroscopy was obtained using a Bruker 600 spectrometer operating at 600 and 
150 MHz, respectively. The instrument is equipped with a 14.1 Tesla Bruker magnet, which is 
controlled by a Bruker AV-II console, and a 5mm Z-gradient TCI Cryo-probe. A 10 second recycle 
delay was used to insure full relaxation between pulses, allowing for quantitative measurements. 
This data was then used to assign individual monomer peaks specific to the ring opening structure, 
thus allowing for the calculation of the polymer’s degree of branching and relative abundance of 
repeat units. 
Gel Permeation Chromatography (GPC)  
Size exclusion chromatography of the glycidol based polymers was performed in DMF at 70°C 
with a flow rate of 1.0mL/min (Waters 1525 binary HPLC pump; columns: 7.8x300mm; Styragel 
HR 5, Styragel HR 4E, and Styragel HR 3: molecular weight range 50,000 to 4x106, 50 to 100,000, 
and 500 to 30,000 g/mol, respectively). A Waters 2414 refractive index detector was employed for 
detection of the polymer species. Polystyrene standards were used for molecular weight 
determination. Polymer samples were measured at a concentration of 10mg/mL and the dn/dc 
value for poly(glycidol) was determined using off-line refractive index measurements. 
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Size-Exclusion Chromatography Tandem Electrospray Ionization Ion Mobility Time-
of-Flight Mass Spectrometry (SEC-Tandem-ESI-IM-TOF-MS) 
In order to fully characterize the polymer structures being formed, a SEC-tandem-MS 
method was developed. SEC of the poly(glycidol) based samples was performed in water 
at 37°C, to simulate ambient body temperature, with a flow rate of 0.8mL/min (Waters 515 
HPLC pump; columns:7.8x300mm; Ultrahydrogel 250, Ultrahydrogel 120, and 
Ultrahydrogel DP 120; molecular weight range 1,000-80,000, 100-5,000, and 100-5,000 
respectively). After SEC was complete, the sample was run through a T joint with one end 
going to a waste collector and the other attached to a Synapt G2-S equipped with a ZSpray 
ESI source. The instrument settings were set to: Polarity: positive; Capillary: 2kV; Source 
T: 80°C. Polymer samples were measured at a concentration of 100µg/mL. Although an 
interesting trend was seen with the drift time of species with different charge states, the 
hardness of the ESI source made the determination of molecular weight with this method 
overly difficult. Thus, MALDI-TOF was chosen as the preferred method for molecular 
weight calculation.  
Matrix Assisted Laser Desorption-Ionization Time-of-Flight Mass Spectrometry (MALDI-
TOF-MS).  
MALDI-TOF-MS measurements were performed using a Voyager DE-STR MS in reflector mode 
equipped with a nitrogen gas laser of wavelength 337nm utilizing external calibration. The 
instrument parameters were set to: 25,000 V; 90% grid; 600ns delay; 1000 shots per spectrum. 
The poly(glycidol) based samples were formed using solutions of 10mg/mL polymer in water and 
saturated CHCA matrix solution in 2:1 water:acetonitrile. In order to determine the molecular 
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weight of the polymer species, direct integration of the obtained peaks was performed. This 
allowed for the calculation of Mn and Mw values, which also allows for the determination of PDI. 
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CHAPTER III 
 
FORMATION OF BIOCONJUGATES UTILIZING POLY(GLYCIDOL) 
Introduction 
The ability to increase the plasma half-life and decrease immunogenicity of readily 
available biological structures has led to some of the most efficacious treatments for many 
debilitating diseases. Since its conception, the field of protein therapeutics has been dominated by 
poly(ethylene glycol) (PEG)1, 2. PEGylation has contributed greatly to the success of treatment 
methods aimed at the delivery of biological therapeutics that would otherwise be of little 
consequence due to the body’s natural desire to rapidly remove anything deemed to be a foreign 
entity. The ‘stealth’ ability of PEG is well documented and as such this method continues to be 
utilized for the formation of protein-polymer conjugates where it is capable of providing a 
protective barrier around the therapeutic, facilitating increased circulation time, greatly increasing 
the utility of the proteins3-5. However, as many of the diseases treated with PEGylated structures 
require lifetime administration of the therapeutic, new studies have seen an increase in immune 
response to the historically used linear PEG species. For this reason, the utilization of branched 
PEG structures, as well as the search for alternatives to PEG with different, and potentially better 
characteristics, is a field that has seen marked growth in the past decade6-9. 
Polymers that are biologically compatible can be conjugated to proteins with therapeutic 
properties to afford systems that have enhanced pharmacokinetic properties. This functionalization 
results in enhanced therapeutic potential, and increased stability of the structures, allowing less 
stringent storage and transfer restrictions7, 10. In order to form the most effective structures, a high 
degree of control is desirable, as well as location specific attachment of the polymer chains to the 
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proteins being functionalized, as both of these factors contribute to the overall efficiency of the 
polymer-protein products6, 11, 12. In hopes of addressing these issues, researchers will often utilize 
genetically engineered proteins which exhibit well defined and readily accessible conjugation sites 
that can be effectively targeted. The formation of protein therapeutics coated in a protective layer 
of PEG is a multi-billion dollar field that has afforded some of the most potent biological 
therapeutics on the market, including treatments for diseases such as diabetes, hepatitis C, and 
even cancer7, 13. 
The new push for better PEG alternatives has explored many avenues, including 
acrylamide derivatives, poly(vinylpyrrolidone), and poly(glycidol) based systems. However, much 
of the work requires the synthesis and purification of polymers with reactive groups that can be 
utilized as anchors for the secondary attachment of these polymers to the surface of the desired 
protein therapeutic. While this method affords some advantages over the possible sizes and 
functionalities of the polymers used, it is a process that requires numerous synthesis and 
purification steps to achieve the protein-polymer conjugate product14, 15. Therefore, it would be 
advantageous to develop a method capable of arriving at a functionalized species through a graft-
from approach. In such an approach, the protein to be conjugated, modified to act as a 
macroinitiator, would be incubated with the monomers necessary for the desired polymerization 
to occur. This method would allow for the directed formation of protein-polymer conjugates in a 
one-step polymerization affording the conjugated species ready for administration9. 
Poly(glycidol) (PG) contains a polyether backbone similar to that seen in PEG and has 
been studied previously as a potential PEG alternative. The synthesis methods used to form these 
PG polymers leads to either purely linear systems, through the utilization of protected monomer 
species, or to hyperbranched polymers similar in architecture to dendrimers14-19. Work with these 
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PG products has shown successful graft-on approaches affording protein-polymer conjugates with 
similar activity as their PEG counterparts. Furthermore, the research has shown that PG polymers 
of semibranched architecture perform better than the linear and hyperbranched structures14, 15. This 
data, together with the ability to control the branching of PG polymers, led to the desire for the 
formation of PG based protein-polymer conjugates using a graft-from method. 
Results and Discussion 
 The facile polymerization of poly(glycidol) is utilized for the formation of protein-polymer 
conjugates with potentially enhanced therapeutic potential. The one pot formation of these graft-
from conjugates allows for direct functionalization of the protein macroinitiators with the 
poly(glycidol) polymer, thus decreasing the steps necessary to arrive at a protein-polymer 
conjugate. This method will be employed for the formation of protein-polymer conjugates of both 
bovine serum albumin (BSA) and lysozyme (LYZ). 
Bovine Serum Albumin Bioconjugates 
 The first protein to be PEGylated in 1977 was BSA, and for this reason it was chosen as 
the first protein to be functionalized with the newly proposed GLYcidation method. It is well 
established that BSA has an easily accessible free thiol on the exterior of the protein which has 
shown the ability for functionalization. As the method of polymerization to be used is ring opening 
polymerization (ROP), the synthesized BSA macroinitiator needs to have an easily accessible 
alcohol group. Therefore, it was decided that a maleimide alcohol would be employed to impart 
the desired hydroxyl characteristic. To facilitate this reaction, the native BSA protein was 
incubated in nitrogen purged phosphate buffer (PB) followed by the addition of the maleimide 
alcohol. After completion, the newly formed macroinitiator was dialyzed and ready to be used for 
the polymerization procedure. 
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 In order to determine the ability to form polymers of different sizes on the surface of the 
proteins, two separate concentrations of glycidol were investigated. Initial polymerization 
reactions were performed in DMSO and DMF with Sn(OTf)2 catalyst present. However, the 
products from these reactions exhibited poor water solubility and led to the need for a different 
approach. It is known that glycidol can undergo autopolymerization in the presence of water, and 
that anionic polymerization mechanisms are capable of forming poly(glycidol) structures (See 
Figure III-1). Therefore, it was decided that a green synthesis route would be followed in which 
the newly formed macroinitiator was solubilized in slightly acidic phosphate buffer (pH= 6.0) 
 
Figure III-1: (Top) Maleimide attachment to BSA protein. (Center) Polymerization of GLY 
Homopolymer from BSA-OH. (Bottom) Polymerization of GLY/AGE Polymer from BSA-OH 
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followed by the addition of glycidol to facilitate the formation of protein-polymer conjugates. The 
products resulting from this reaction were well soluble in water and easily purified through 
dialysis. 
Introduction of a Functional Monomer Unit 
 The newly discovered method for the facile formation of protein-polymer conjugates was 
very exciting, but the ability to incorporate functional monomers, capable of undergoing secondary 
reactions once attached to the protein, is an intriguing notion. In order to investigate this possibility, 
subsequent reactions were run in which allyl glycidyl ether (AGE), a readily available glycidol 
derivative, was added to the reaction mixture. The resulting products were investigated using 1H 
NMR and showed successful incorporation of the allyl moiety. Containing a range of thiolated 
structures, which can be used for secondary modifications such as targeting units, through the use 
of thiolene-click reactions, these newly formed species can be utilized as protein-polymer 
conjugates with elevated potential  
Characterization of Bioconjugate Sizes 
MALDI-TOF mass spectrometry was found to be an ideal tool to determine the success of 
the graft-from approach and to quantify the molecular weight increase (Figure III-2).  The first set 
of experiments afforded a 1kDa increase in the molecular weight of BSA. To demonstrate a more 
apparent change in molecular weight, the amount of glycidol was increased to 4 fold and an 
increase in the molecular weight of the BSA of up to 10K was observed.  
Most surprisingly, the reactions conducted in buffer yielded species with the highest 
molecular weight increase. This finding may indicate a catalytic promotion of the slightly acidic 
buffer (pH 6.0) accelerating the polymerization of the glycidol and is the subject of further studies. 
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With this, a practical method to grow polyglycerols from proteins in physiological environments 
was created. 
Polyacrylamide electrophoresis (PAGE) was employed to further support the evidence of 
a successful polymer-protein conjugation. Figure III-3 shows lanes with BSA (lane 2), BSA-OH 
macroinitiator (lane 3) and conjugated protein-polymer products (lanes 4-6) in the three selected 
solvents and at the highest glycidol monomer concentration. The PAGE confirmed the molecular 
weight increases of the samples via the graft-from method and the products appear as high 
molecular weight bands slightly above the BSA standard. The polymer-protein conjugate reaction 
conducted in buffer showed a substantial molecular weight increase in PAGE in comparison with 
the other samples and confirmed the MALDI-TOF measurements.    
Measurement of Retained Bioactivity 
To determine the bioactivity of the polymer-protein conjugates, the species were allowed 
to react with 4-nitrophenyl acetate and the absorbance of the resulting hydrolysis product was 
 
Figure III-2: (Left) MALDI-
TOF Characterization of the 
GLYcidated BSA products. 
(Above) SDS-PAGE of the 
GLYcidated BSA products 
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measured using UV/Vis spectroscopy.                             the bioactivity assay indicated only a slight 
 
 
Figure III-3: (Top) Bioactivity investigation of BSA polymer-protein conjugates. (Bottom) 
Circular Dichroism investigation of BSA polymer-protein conjugates  
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measured using UV/Vis spectroscopy (See Figure III-3). The results of the bioactivity assay 
indicated only a slight decrease in activity in comparison with the unmodified BSA protein. 
Protein-polymer conjugates formed with the lower concentration of 0.33M are shown in Figure 
III-4. All samples show a high activity that is close to or higher than the BSA-OH macroinitiator. 
The lowest bioactivity is observed for the sample conducted in DMSO. The polymer-protein 
conjugate obtained from reactions with 1.33M in PB, which yielded the highest increase in 
molecular weight (10K), showed a lower bioactivity of 0.02. Since the reactions run at 1.33M were 
performed to validate the developed method, future studies will attempt to achieve sufficient 
solubilization and stability with the shortest polyglycerol chains possible to limit the adverse effect 
on bioactivity.  
Investigation of Structural Changes 
The final characterization method employed was circular dichroism (Figure III-3). This 
particular measurement is able to determine the influence that the polymer conjugation reaction 
has on the 3-dimensional structure of the BSA protein. These structural characteristics must be 
maintained in order to ensure the protein will behave as it should. The measurements taken show 
a similar trend to the bioactivity measurements, with the DMSO reaction exhibiting a significant 
change in structure while the reactions conducted in PB and DMF have a minimal effect on the 
BSA protein. This information affords another argument in favor of the GLYcidation of the protein 
and allows for the assumption that the formulated process does not overtly influence the structure 
of the protein being functionalized. 
Lysozyme Bioconjugates 
The intriguing data garnered from the work done with BSA, coinciding with the minor 
reduction in protein activity, led the researcher to experiment with a more biologically relevant 
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protein, the antimicrobial lysozyme (LYZ). Unlike BSA, LYZ possess seven pendant amine 
groups, though only one functionalized group is desired. In order to afford a LYZ macroinitiator, 
the LYZ was incubated with an aldehyde thiol to allow for the formation of a Schiff base which 
was subsequently reduced with 2-picoline borane complex to yield the desired diol functionalized 
product (Figure III-4). Due to their green nature, and based on the fact that they yielded the least 
disrupted BSA products, only the PB reaction conditions were used, though a more thorough time 
and concentration study was performed. The reaction time was not limited to 24h, but reaction 
times included 4h, 8h, 16h, 24h, and 48h, and each reaction time was used to form LYZ products 
at both 1.33M and 2.66M with respect to GLY concentration. This range of reactions provided 
protein conjugates with a seemingly more linear time dependent polymer growth, while the more 
 
Figure III-4: (Top) Maleimide attachment to LYZ protein. (Center) Polymerization of GLY 
Homopolymer from LYZ-OH. (Bottom) Polymerization of GLY/AGE Polymer from LYZ-OH 
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concentrated reactions did not yield species with drastically increased molecular weights as was 
observed in the BSA study. The synthesis of a LYZ-GLY/AGE species was also performed to 
afford a product species with readily available allyl units. 
Effect of Reaction Time and Concentration on Functionalization 
 
The use of PAGE was quantitatively useful to demonstrate the increase in conjugate size 
with respect to reaction time as well as concentration. Figure III-5 shows lanes with LYZ (lane 2), 
LYZ-OH (lane 3), a 4h reaction at 1.33M (lane 4), a 24h reaction at 1.33M (lane 5), a 24h reaction 
at 2.66M (lane 6), and the polymerization of GLY/AGE using the LYZ-OH macroinitiator (lane 
7). While the PAGE confirms an increase in size of the conjugates based upon reaction time as 
Figure III-5: (Left) MALDI-TOF 
Characterization of the GLYcidated 
Lysozyme products. (Above) SDS-PAGE of 
the GLYcidated LYZ products. LYZ (lane 
2), LYZ-OH (lane 3), 4h at 1.33M (lane 4), 
24h at 1.33M (lane 5), 24 h at 2.66M (lane 
6), LYZ-O-GLY/AGE (lane 7) 
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well as concentration, the concentration of the reaction is a more subtle variation that becomes 
more prevalent upon the acquisition of subsequent measurements.  
In order to further investigate the change in mass achieved, MALDI-TOF was employed 
to obtain quantitative measurements of the polymer that was grown from the surface of the LYZ 
protein. Figure III-5 illustrates the functionalization that was achieved by attachment of the 
aldehyde diol and subsequent growth of the glycidol polymer from the surface of the 
functionalized LYZ protein. The LYZ protein is shown in green while the synthesized 
macroinitiator appears in blue. The two product species shown are 24h reactions at 1.33M and 
2.66M respectively. This data alludes to the fact that the reaction time more directly influences the 
length of the polyglycerol grown from the surface than does the reaction concentration. 
Measurement of Retained Bioactivity 
Since LYZ is an antimicrobial protein, the activity of the GLYcidated LYZ products can be 
measured against Micrococcus lysodeikticus (Ml) cells and compared to the activity of the native 
LYZ protein. As the LYZ conjugates lyse the micrococcus cells, a reduction in absorption at 
λ=450nm was measured over the course of 3 minutes using UV/Vis Spectroscopy. The results 
were similar to those seen with PEG systems wherein an increase in molecular mass of the attached 
polymer structure leads to a reduction in overall protein activity and are illustrated in Figure III-6. 
The activity values obtained ranged from ~40% down to 3% which, compared to hyperbranched 
structures of similar molecular mass, are slightly lower than the values seen for hyperbranched 
polyglycerol.14 This observation may be due to the formation of multiple polymer chains on the 
surface of the protein, and is an issue that will be investigated further in hopes of providing systems 
with higher degrees of activity retention. However, it is hypothesized that, as is the case with PEG 
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structures, this decrease in activity will be greatly overshadowed by an increase in circulation time 
within the body, thus allowing for an overall increase in the therapeutic ability of the protein.  
Conclusion 
 The research describes the first method developed for the direct functionalization of protein 
species via a graft-from reaction to form poly(glycidol) based protein-polymer products. This is 
an exciting new technique providing a facile method for the formation of these species, which 
opens the door for new and more versatile protein therapeutics. Furthermore, the incorporation of 
secondary reactive groups affords readily functionalized protein architectures that can be tagged 
with fluorophores, targeting agents, or incorporated into nanonetworks. 
 
Figure III-6: Bioactivity of the lysozyme-polymer conjugates is measured using Ml cells. As 
the conjugates lyse the Ml cells, a change in absorbance can be measured using UV-Vis 
Spectroscopy 
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Experimental 
Materials 
Glycidol (Sigma Aldrich, 96%) was vacuum distilled prior to use. The m-CPBA (77%) was 
purified as previously reported in the literature. Allyl glycidyl ether (Sigma Aldrich, ≥99%), 
Phosphate Buffer (Sigma Aldrich), DL-glyceraldehyde (Strem Chemicals Inc., 98%), 2-picoline 
borane (Sigma Aldrich Inc., 95%), sodium nitrate (Sigma Aldrich Inc., 99%), Lysozyme from 
chicken egg white lyophilized powder (Sigma Aldrich Inc., 90%), sinapic acid (Sigma Aldrich 
Inc., 98%), Micrococcus lysodeikticus ATCC No. 4698 lyophilized cells (Sigma Aldrich Inc.), 3-
Buten-1-ol (Sigma Aldrich Inc.), tin(II) trifluoromethanesulfonate (Strem Chemicals Inc., 99%), 
N,N-dimethylformamide (DMF, Sigma Aldrich 99.8%), N,N,N′,N′-ethylenediaminetetraacetic 
acid (EDTA, Sigma Aldrich, 99.4-100.6%), triethylamine (Sigma Aldrich, ≥99%), bovine serum 
albumin (BSA, Aldrich, Approx. 99%), 5,5′- dithio-bis-(2-nitrobenzenzoic acid) (Ellman’s 
reagent, Aldrich, 99%), tris(2-carboxyethyl)phosphine hydrochloride (Sigma Aldrich, TCEP, ≥98 
%),and 4-nitrophenyl acetate (Fluka, ≥99%) were used as received. Dialysis membranes 
(SnakeSkin, molecular weight cut-off (MWCO): 10,000 Da) were obtained from Thermo 
Scientific. Dialysis membranes (Spectra/Por® 7, molecular weight cut-off (MWCO): 25,000 and 
50,000 Da) were obtained from Spectrum Laboratories, Inc. Precise Tris-glycine 12% pre-cast 
PAGE gels were obtained from Fisher Scientific Company.  
Characterization 
1H and 13C NMR spectroscopy was performed using a Bruker 600 spectrometer operating at 600 
and 150 MHz, respectively. The instrument is equipped with a 14.1 Tesla Bruker magnet, which 
is controlled by a Bruker AV-II console, and a 5mm Z-gradient TCI Cryo-probe. A 20 second 
recycle delay was used to insure full relaxation for quantitative measurements, which allowed for 
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the elucidation of specific monomer unit peaks and subsequent calculation of the degree of 
branching present in each glycidol homopolymer. MALDI measurements were accomplished 
using a Voyager DE-STR MS in linear TOF mode equipped with a nitrogen gas laser at λ= 337nm 
with external calibration. The individual instrument parameters varied based on the samples being 
characterized. PAGE measurements were accomplished using an Invitrogen x-cell electrophoresis 
system from Life Technologies. 12% Precise Tris-glycine gels from Thermo Scientific were used 
for BSA conjugates. Novex NuPage 4-12% Bis-Tris gels were used for LYZ Conjugates. The gels 
were then removed from their cartridges and washed three times with DI water, with one 30 minute 
water soak, before being stained with Coomassie Blue gel stain. Gels were then stored in DI water. 
Size exclusion measurements were obtained with a Waters chromatograph system equipped with 
a Waters 2414 refractive index detector, a Waters 1525 binary HPLC pump, and four 5 mm Waters 
columns (300 mm x 7.7 mm), connected in series with increasing pore size (100, 1000, 100,000 
and 1,000,000 Ǻ respectively). All runs were performed with N-N-dimethylformamide (DMF) as 
the eluent at a flow rate of 1 mL/min. Ultraviolent/Visible spectroscopy data was obtained using 
an Agilent 8453 UV/Vis spectrometer with a photodiode array detector. Kinetic measurements 
were obtained by collecting the absorbance at 450nm every 15s for 3 minutes. 
Conjugation of BSA with Maleimide Alcohol to obtain BSA Alcohol Conjugate 
BSA (0.5g, 7.5 μmol, 1 eq) was dissolved in phosphate buffer (PB) solution (37.5mL, pH 7.2) in 
a 100mL round bottom flask equipped with a magnetic stir bar and was then purged under N2(g) 
for 1h. 1-(2-hydroxyethyl)-1H-pyrrole-2,5-dione (21.23mg;  6x10-5 mol; 20 eq) was solubilized in 
nitrogen-purged DMF (2.5mL). The maleimide solution was then added dropwise to the stirring 
BSA solution and the reaction was allowed to run for 20h @ 25°C. The resulting reaction mixture 
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was dialyzed against deionized (DI) water for 36h using a MWCO of 25,000 Da, and then 
lyophilized to isolate the BSA Alcohol Conjugate (BSA-OH). Yield: 32.7mg (79.2%) 
General Procedure for the Polymerization of GLY using BSA-OH in different Solvent 
Systems 
Sn(OTf)2 (0.87mg, 2.1μmol), BSA-OH (80mg, 1.2μmol), and DMF (3.6mL) were added to a 25mL 
round bottom flask equipped with a magnetic stir bar and purged with N2(g) for 30 minutes in an 
ice bath. The glycidol monomer (79.4μL, 1.19mmol) was then added by syringe and the reaction 
was allowed to run for 24h at 25°C. The resulting reaction mixture was dialyzed against DI water 
for 36h using a MWCO of 25,000 Da, and then lyophilized to isolate the BSA Glycidol Conjugate 
(BSA-GLY). 
This reaction was repeated with the DMF replaced with either PB (pH=6.0; no Sn catalyst) or 
DMSO in order to ascertain the optimal reaction conditions. The products obtained from these 
three solvent systems were visibly different with a seeming decrease in solubility in the trend: 
PB>DMF>DMSO. However, apart from this caveat, the reaction procedure remained unchanged. 
Polymerization of GLY/AGE using BSA-OH 
This procedure was modified from an earlier reported procedure. BSA (1g, 15.1μmol), and PB pH 
6.0 (46.8mL) were added to a 100mL round bottom flask equipped with a magnetic stir bar and 
purged with N2(g) for 30 minutes in an ice bath. The GLY (15.1mmol, 1.03mL) and AGE 
(15.1mmol, 1.79mL) was then added by syringe and the reaction was allowed to run for 24h at 
25°C. The resulting reaction mixture was dialyzed against DI water for 36h using a MWCO of 
10,000 Da, and then lyophilized to isolate the BSA GLY/AGE Conjugate (BSA-GLY/AGE). 
Yield: 27.4mg (84.1%). Relevant 1H-NMR peaks at 5.86 , 5.23 , 3.57, show inclusion of AGE into 
the polymer backbone attached to the BSA protein. 
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PAGE Characterization of BSA-Polymer Conjugates 
PAGE was accomplished using an Invitrogen Novex Mini-Cell system. Precast 12% PreciseTM 
Protein Gels (Thermo Scientific) were run at 100V and 120mA for 1.75 hours. Solutions were 
prepared with a BSA concentration of 6g/L in DI water. PAGE samples were formed by mixing 
7.5μL of BSA solution with 2.5μL 4x LDS sample buffer (Invitrogen) before loading the 10μL 
solutions onto the gel plate. Staining of the gels was accomplished using Coomassie Blue. 
MALDI Characterization of BSA Based Bioconjugates 
MALDI-TOF MS was employed to confirm the addition of the maleimide alcohol initiator to the 
BSA protein and the subsequent glycidol polymer growth from the BSA-OH conjugate. The 
MALDI samples were formed using 6mg/mL product samples in DI water and a 5mg/mL matrix 
solution of sinapic acid dissolved in 2 parts 0.1% formic acid, 1 part acetonitrile. The sample and 
matrix were mixed in a 1:1 ratio and 1.4μL was spotted onto the MALDI plate for characterization. 
The instrument parameters were set to: 25,000V; 90% grid; 600ns delay; 1000 shots per spectrum. 
Determination of BSA-Polymer Conjugates Bioactivity 
The bioactivity of the synthesized BSA-OH conjugates and subsequent polymer coated species 
was determined and compared to the native BSA protein by measuring the absorbance related to 
the hydrolysis product with 4-nitrophenyl acetate. Sample preparation was performed by 
combining a BSA or BSA conjugate solution (50μL, [BSA]=0.27mM) in PB (pH=8.0) with a 
10mM solution of 4-nitrophenyl acetate dissolved in acetonitrile (10μL) and PB (0.94mL, pH=8.0) 
and centrifuging the samples for 5 minutes at 6,000 rpm. The samples were allowed to incubate 
for 30 minutes at room temperature before measuring the absorbance at λ= 405nm to determine 
the bioactivity of each sample. 
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Circular Dichroism  
The use of CD spectrophotometry was employed to verify the retention of the secondary structure 
of the BSA protein. Spectra were obtained with a Jasco J-720 at 25 ± 1 °C in DI water (1.5x10-5 
M) in a cell with a path length of 1cm (bandwidth=1 nm; step resolution = 0.5 nm; scan speed = 
50nm/min; response time = 0.5s). Spectral data was collected from 190-275 nm to ascertain 
information about the a-helix structure of the BSA protein as well as the structure of the BSA 
conjugates formed. 
Conjugation of LYZ with Aldehyde Diol to Obtain LYZ Alcohol Initiator 
In a 500mL RBF, equipped with stir bar, was added DL-glyceraldehyde (6.3mg; 70µmol) along 
with 50mM NaNO3 (250mL). Lysozyme (1.0g; 70µmol) was solubilized in a minimal amount of 
50mM NaNO3 solution and added dropwise to the stirring reaction. After 1h, the 2-picoline borane 
complex (150mg; 1.4mmol) was added proportionally and the reaction was allowed to stir 
overnight. The product solution was then placed in dialysis tubing (SnakeSkin; 10,000 MWCO) 
and dialyzed against 50mM NaNO3 solution for 72 hours. The product was then lyophilized to 
afford the pure LYZ-OH product. Yield: 767.4 mg (76.7%) 
Polymerization of GLY using LYZ-OH 
LYZ-OH (200mg; 14µmol), and PB (pH 6.0; 42.1mL) were added to a 100mL RBF equipped with 
a stir bar. The glycidol monomer (4.14g; 56mmol) was then added by syringe and the reaction was 
allowed to run for 24h at 25°C. The resulting reaction mixture was dialyzed against DI water for 
36h using a MWCO of 10,000 Da, and then lyophilized to isolate the LYZ-Glycidol Conjugate 
(LYZ-GLY). Yield: 26.2mg (83.4%) 
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Polymerization of GLY/AGE using LYZ-OH 
LYZ-OH (112mg; 7.8µmol), and PB (pH 6.0; 42.1mL) were added to a 100mL RBF equipped 
with a stir bar. The glycidol monomer (2.31g; 31.3mmol) and allyl glycidyl ether monomer (3.57g; 
31.3mmol) were then added by syringe and the reaction was allowed to run for 24h at 25°C. The 
resulting reaction mixture was dialyzed against DI water for 36h using a MWCO of 10,000 Da, 
and then lyophilized to isolate the LYZ-Glycidol Conjugate (LYZ-GLY). Yield: 17.4mg (55.8%) 
PAGE Characterization of LYZ-Polymer Conjugates 
PAGE was accomplished using an Invitrogen Novex Mini-Cell system. Precast 12% PreciseTM 
Protein Gels (Thermo Scientific) were run at 100V and 120mA for 1.75 hours. Solutions were 
prepared with a LYZ concentration of 6g/L in DI water. PAGE samples were formed by mixing 
7.5μL of BSA solution with 2.5μL 4x LDS sample buffer (Invitrogen) before loading the 10μL 
solutions onto the gel plate. Staining of the gels was accomplished using Coomassie Blue. 
 MALDI Characterization of LYZ Based Bioconjugates 
MALDI-TOF MS was employed to confirm the addition of the DL-glyceraldehyde diol initiator 
to the LYZ protein and the subsequent glycidol polymer growth from the LYZ-OH conjugate. The 
MALDI samples were formed using 6mg/mL product samples in DI water and a 5mg/mL matrix 
solution of sinapic acid dissolved in 2 parts 0.1% formic acid, 1 part acetonitrile. The sample and 
matrix were mixed in a 1:1 ratio, and 1.4μL was spotted onto the MALDI plate for characterization. 
The instrument parameters were set to: 25,000V; 90% grid; 500ns delay; 500 shots per spectrum.  
Determination of the LYZ-Polymer Conjugates Bioactivity 
A suspension of M1 cells (19.4mg) was formed in PBS buffer solution (90mL, pH 7.0), while 
lysozyme solutions were formed (1.0 mg/mL in PBS buffer, pH 6.5). In order to measure the 
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bioactivity, a small aliquot of the lysozyme solution (5.0µL) was transferred to a blanked cuvette. 
The M1 cell suspension (3.0mL) was then added to the cuvette, and a kinetic UV-Vis measurement 
was performed by measuring the absorbance at wavelength 450nm every 15s for 3 min. 
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CHAPTER IV 
 
NANOSCALE NETWORK FORMATION 
Introduction 
 The realm of medicinal chemistry is full of highly efficacious small molecule drugs. 
Unfortunately, this high degree of effectiveness is often accompanied by a low degree of solubility 
and/or permeability1-4. This unfavorable combination means that the majority of these drug 
molecules can never be employed directly to combat the diseases they were synthesized to cure. 
Due to these facts, a good amount of polymer research has been focused on the development of 
drug delivery platforms capable of imparting the necessary solubility to hitherto unused drug 
molecules5-8. Furthermore, research in the polymer nanoparticle field has endeavored to create 
delivery vehicles capable of sustaining the release of their cargo over an extended period of time 
in order to decrease the time patients spend with their doctors, and increase the patients’ quality of 
life. The goal tying all this research together is the development of a facile fabrication method 
yielding a platform capable of providing a single therapeutic dose of a highly efficacious drug by 
imparting solubility and extended release of the desired therapeutic5, 7, 9-12. 
 Current research in the field of nanoparticle drug delivery focuses mainly on the 
development of a single delivery vehicle with minimal adjustability in drug delivery rate or cargo 
specificity. Drug release from such platforms is often very fast at first, a burst effect, followed by 
the complete clearance of the payload within the first 48 hours. Nanoparticles formed through 
emulsion reactions, often from the utilization of block copolymer building blocks, afford products 
with definable size and release rate, but these characteristics rely heavily on the type of copolymer 
and surfactant used, and allow little ability for tuning without large changes to the reaction 
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parameters1, 2, 13-15. Similar structures can be easily developed using micelle based delivery 
systems, but again these platforms suffer from rapid delivery of their therapeutic cargo3, 11, 16, 17. In 
order to combat these shortcomings, a number of platforms have focused on the formation of 
prodrug based delivery wherein the desired therapeutic is covalently attached to the polymer 
structure and can be released in the presence of a predetermined stimuli.18-20. Unfortunately, this 
method is not well adapted for broad application, and thus the door is open for a delivery vehicle 
capable of sustained release of therapeutics with minimal limitations based upon cargo and highly 
tunable parameters based on polymer characteristics. 
 While the majority of nanoparticle fabrication relies heavily on self-assembly, the ability 
to direct the formation of nanoparticle structures through covalent bonding allows for the 
introduction of an easily tunable characteristic. Furthermore, by altering the degree of crosslinking 
one can easily change the density of the formed structure and impart varying release kinetics to 
the delivery vehicle. For these reasons it was decided that polymeric nanoparticles would be 
synthesized from two separate polymer species. First, a linear poly(ester) based polymer will be 
used to form semi-hydrophobic structures for the delivery of highly hydrophobic cargo. Second, a 
branched poly(glycidol) based polymer will be employed to form hydrophilic delivery vehicles for 
the purpose of biological cargo delivery. These two systems will utilize the thiolene-click reaction 
for nanoparticle formation and will be directly compared to investigate the level of control possible 
over the size of the formed nanoparticles. 
Results and Discussion 
Synthesis of Monomer Building Blocks 
 The utilization of thiolene-click chemistry for nanoparticle formation necessitates the 
presences of allyl functionality within the backbone of the synthesized polymer products. 
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However, such monomers are not always easily purchased. Therefore, a number of monomer units 
for the proposed research were synthesized in order to impart variable hydrophilicity as well as 
the necessary allyl functionality. For the hydrolytically degradable poly(ester) system, monomers 
previously described in the literature were chosen, while for the poly(glycidol) system a novel 
monomer was synthesized. 
Synthesis of an Allyl Functionalized Lactone 
 The ability of lactones to undergo ring opening polymerization for the formation of linear 
poly(ester) structures has been described previously in the literature4, 6, 21-23. Furthermore, it has 
been shown that the introduction of an allyl functionality to the ring structure can be easily 
facilitated to afford an allyl functionalized random copolymer capable of undergoing secondary 
modification or direct utilization, via thiolene-click chemistry, as a nanoparticle building block. 
For this reason it is necessary to synthesize the desired α-allyl‐δ‐valerolactone monomer species. 
The method chosen, described previously in the literature, involved the activation of the lactone 
ring with diisopropylamine and n-butyl lithium followed by the addition of the desired allyl 
functionality through reaction of the activated ring with allyl bromide21. 
Synthesis of an Ester Monomer with Increased Hydrophilic Potential 
 Though the poly(ester) polymer structure is hydrolytically degradable, the polymer suffers 
from low solubility. In an effort to combat this undesirable characteristic it was decided that 2-
oxepane-1,5-dione would be added as a comonomer in the poly(ester) synthesis. This monomer 
introduces a keto group into the backbone of the polymer with each incorporated monomer unit, 
facilitating an increase in hydrophilicity while maintaining the desired ester moiety. This monomer 
was formed as previously described in the literature, and is synthesized by the reaction between 
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1,4-cyclohexanedione and purified meta-chloroperoxybenzoic acid, leading to the insertion of an 
oxygen adjacent to one of the ketones on the ring23. 
Synthesis of Novel Allyl Glycidyl Ester Monomers 
 In the case of glycidol based monomers, there is a readily available allyl functionalized 
monomer, allyl glycidyl ether, which can afford poly(glycidol) based copolymers with the desired 
allyl functionality. However, as the goal of this project is to create a biologically degradable drug 
delivery vehicle, a monomer was needed that would not only impart the desired allyl functionality 
but also introduce an easily cleavable moiety, such as an ester. For this reason a novel monomer 
species was synthesized to combine their desired regions: an epoxide for rapid ring opening, an 
ester for inherent degradability, and an allyl for secondary utilization for crosslinking and 
nanoparticle formation. This monomer was successfully formed using a two-step process (See 
Figure IV-1). First, allyl alcohol was reacted with 4-pentenoyl chloride under dry conditions to 
afford a diallyl species with an ester in the middle. Subsequently, this product was treated with 1 
molar equivalent of m-CPBA to facilitate the epoxidation of a single allyl species. The resultant 
glycidyl ester allyl monomer unit successfully incorporated the three desired regions and was 
utilized as a comonomer for the synthesis of functionalized poly(glycidol) polymers. 
 
 
Figure IV-1: Synthesis of a novel glycidol based monomer unit 
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Synthesis of Polymer Building Blocks 
Allyl Functionalized Poly(ester) Polymers 
 The allyl functionalized polymer products were synthesized similarly to those described 
previously, with the caveat that the oxepane-2-dione monomer was added at varying percentages 
to produce products of variable hydrophilic character (See Figure IV-2). The polymerization was 
performed in bulk conditions utilizing Sn(OTf)2 as a catalyst and isoamyl alcohol as the ring 
opening initiator. Random copolymers were obtained after 24 hours and characterized using 1H 
NMR and GPC measurements. The ability to incorporate variable amounts of both AVL and OPD 
 
Figure IV-2: Synthesis of the poly(ester) building block with allyl functionality and increased 
hydrophilicity 
69 
 
means that the synthesized polymers contain a range of crosslinking and hydrophilic character, 
allowing for numerous particle formulations. The ability to tune the crosslinking density of the 
formed nanoparticles is very important as this characteristic has been shown to dictate the release 
rate of the loaded therapeutic cargo. 
Allyl Functionalized Poly(glycidol) Polymers 
 Though the synthesis of glycidol polymers has been a topic of research for many years, the 
post-modification of the polymer systems in order to afford structures with enhanced reaction 
 
 
 
 
 
 
 
Figure IV-3: Synthesis of the poly(glycidol) building block with allyl functionality  
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capability is a fledgling field of study24-28. The majority of previously synthesized structures have 
been used directly for applications such as biomineralization, solid phase catalysis, etc.,18, 27, 29, 30 
and few researchers have sought to fundamentally change the composition of these glycidol 
structures. However, the advantages of the formation of functionalized glycidol polymers are vast 
and attracted our interest in the hopes of expanding the usefulness of the glycidol based polymers. 
A range of post-modification reactions, as well as the implementation of glycidol derivatives, were 
considered with numerous end goals for the proposed products. These included the introduction of 
ester functionalities to impart hydrolytic degradability, as well as the addition of either allyl or 
primary thiol moieties for intra and intermolecular interactions. The ester functionalities allow for 
a polymer system capable of hydrolytic release of bound molecules, be these other polymer chains 
in the case of nanoparticle formation, or therapeutic cargo. As this ester functionality yields a 
desired characteristic, allyl and thiol containing molecules were chosen that afforded 
functionalized polymers with both the ester and desired allyl or thiol moiety.  
Utilization of Functional Monomer Units  
Allyl functionalized poly(glycidol) precursors were formed using both the available allyl 
glycidyl ether monomer (See Figure IV-3) and the newly synthesized glycidyl ester allyl. 
Furthermore, a range of allyl percentages were formed in order to facilitate the synthesis of 
nanoparticles with variable crosslinking densities. The polymerization reaction was similar to that 
utilized for the poly(ester) systems, though the allyl monomer was added prior to the addition of 
the glycidol monomer due to the relative difference in reaction rate, with glycidol being a highly 
reactive species. Random copolymers were obtained after 16 hours and using 1H NMR and GPC 
measurements. The resulting polymers showed good incorporation, though the GEA monomer was 
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not incorporated at the same level as the AGE monomer, with 7% and 13% allyl incorporation 
achieved, respectively, when attempting 20% allyl incorporation. 
Secondary Functionalization of Poly(glycidol) Homopolymers 
 In the formation of the GEA monomer, 4-pentenoyl chloride is used to form the DAE 
intermediate molecule. It stands to reason that the acid chloride would rapidly react with the 
pendant hydroxyl groups on the glycidol polymer structure. This theory was tested through a neat 
reaction with the glycidol polymer, acid chloride, and pyridine as a base to scavenge the HCl 
byproduct. The synthesis route afforded polymer systems with predictable allyl functionalization 
and ester incorporation. 
In order to incorporate the desired thiol functionalization, the previously synthesized DSL 
molecule was utilized.31 As this molecule contains a carboxylic acid rather than an acid chloride, 
the DSL was treated first with thionyl chloride to afford the acid chloride derivative DSL-Cl. This 
product was then used to functionalize the glycidol polymer backbone in a method similar to that 
used for 4-pentenoyl chloride. The purification of the synthesized product proved to be more 
difficult than expected but was accomplished through the implementation of HPLC separation. 
This afforded the functionalized glycidol product with both ester incorporation and a readily 
cleavable dithiol species. 
Structural Comparison Between Poly(ester) and Poly(glycidol) Nanosponges 
 In order to investigate the inherent differences conferred on the nanoparticle structures 
based upon the polymers chosen for their creation, a number of nanosponges were formed. All 
reactions use thiolene-click reactions to facilitate the rapid reaction between the free thiols of the 
PEG crosslinker and the pendant allyl functionalities on the synthesized polymer species. The 
nanosponge formation is accomplished by solubilizing the synthesized polymers with a PEG 
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spaced dithiol crosslinker and subsequently refluxing the solution for 12 hours to allow the 
thiolene-click reaction to covalently bond the polymers together. For the poly(ester) systems this 
was accomplished in dichloromethane, while the poly(glycidol) systems were formed in methanol. 
To fully investigate the relative influence that crosslinking density has on the synthesized particles, 
a range of cross linking equivalents and allyl percentages was studied. This investigation showed 
that the use of different molar equivalents of cross linker causes a shift in the size of the particles 
formed, with the smallest particle species coming when there is a 1:1 relationship between allyl 
and thiol. When comparing the two separate polymer based particles however, it was interesting 
to see that polymers with similar allyl incorporation and the same molar equivalents of crosslinker 
yielded particles of disparate sizes, with smaller particles formed from the poly(glycidol) based 
Figure IV-4: Synthesis and characterization of the poly(ester) based nanoparticle structure  
A 
B 
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systems. However, the poly(ether) systems tended to form particle structures with lower size 
disparity, which is a logical occurrence since the poly(glycidol) structures are branched and less 
able to form consistent interactions between the polymer chains.  
Loading of Poly(ester) Nanosponges with Therapeutic Cargo 
 The ability to load a small molecule therapeutic into the formed nanosponge networks is 
paramount to their ability to be utilized as drug delivery vehicles. Furthermore, it is desirable to 
load therapeutics with specific thoughts in mind as to the desired delivery method. Building on 
Figure IV-5: Synthesis and characterization of the poly(glycidol) based nanoparticle structure  
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previous work in the lab that sought to shuttle brimonidine across the optic nerve, bypassing the 
blood brain barrier, the synthesized poly(ester) nanosponges were loaded with temozolomide, a 
brain cancer therapeutic with notoriously low bioavailability. As the desired delivery method 
involved deposition of the drug loaded particles to the region adjacent to the optic nerve, larger 
particles were chosen for their ability to carry more of the temozolomide molecule. The drug was 
loaded into the nanosponge structure as previously described, and successful incorporation of the 
drug was determined using UV/Vis. 
Conclusion 
  In summary, we have successfully shown that nanoparticles can be formed from both 
poly(ester) and poly(glycidol) based starting materials. Work with the poly(ester) nanoparticle 
platform has been accomplished previously in the lab. However, the research in this section 
represents the first successful formation of poly(glycidol) based nanoparticles using similar 
reaction conditions as those utilized for the poly(ester) system. The pendant allyl groups on the 
back of both polymer systems were utilized for the successful crosslinking of the particles using a 
dithiol molecule in order to form nanoparticle products. Furthermore, these nanoparticles were 
formed at different sizes by using varying crosslinking densities and amount of allyl functionality 
available. This exciting discovery opens the door for the utilization of these novel nanosponge 
architectures as delivery platforms for therapeutic cargo. 
Experimental 
Materials 
All reagent chemicals were purchased from Sigma-Aldrich, Strem Chemicals, or Acros and used 
as received unless otherwise noted. The m-CPBA (77%) was purified as previously reported in the 
literature while δ-valerolactone and glycidol was further purified through vacuum distillation. 
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SnakeSkin® Pleated Dialysis Tubing, regenerated cellulose, was purchased from Pierce 
Biotechnology. Spectra/Por® Dialysis membrane was purchased from Spectrum Laboratories Inc. 
α-allyl-δ-valerolactone, α-propargyl-δ-valerolactone, and 2-oxepane- 1,5-dione were synthesized 
as previously reported in the literature. 
Characterization 
1H and 13C NMR were obtained from a Bruker AV-I 400 MHz, a Bruker DRX 500 MHz, or a 
Bruker AV-II 600 MHz spectrometer. The reported chemical shifts are in ppm and are in reference 
to the corresponding residual nuclei in deuterated solvents. Gel-permeation chromatography 
(GPC) was carried out with a Waters chromatograph system equipped with a Waters 2414 
refractive index detector, a Waters 2481 dual λ absorbance detector, a Waters 1525 binary HPLC 
pump, and four 5 mm Waters columns (300 mm x 7.7 mm), connected in series with increasing 
pore size (100, 1000, 100,000 and 1,000,000 Ǻ respectively). All runs were performed with N-N-
dimethylformamide (DMF) as the eluent at a flow rate of 1 mL/min. Samples for transmission 
electron microscopy (TEM) imaging were prepared by dissolving 0.5 mg nanoparticles in 1 mL 
isopropanol, 0.3 mL acetonitrile and 0.2 mL toluene. The samples were sonicated for 5 min and 
were stained with 3 drops of 3% phosphotungstic acid. The carbon grids were prepared by slowly 
dipping an Ultrathin Carbon Type-A 400 Mesh Copper Grid (Ted Pella, Inc., Redding, CA) into 
the particle solutions three times and drying the grid at ambient temperature. A Philips CM20T 
transmission electron microscope operating at 200 kV in bright-field mode was used to obtain 
TEM micrographs of the polymeric nanoparticles. 
Synthesis of α-allyl-δ-valerolactone (AVL) 
This reaction was performed as previously described in the literature with the use of vacuum 
distilled δ-valerolactone (VL) rather than using the purchased purity. 1H-NMR (400MHz, CDCl3) 
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δ: 5.80 (1H, m, CH) 5.04 (2H, m, CH2), 4.27 (2H, m, CH2), 2.42 (2H, m, CH2, CH), 2.18 (1H, m, 
CH2), 2.00-1.72 (4H, m, CH2). 
13C-NMR (100MHz, CDCl3) δ: 173.98, 135.03, 117.54, 68.84, 
39.13, 35.42, 22.13, 21.05. 
Synthesis of 2-oxepane-1,5-dione (OPD) 
This reaction was performed as previously described in literature with the use of purified m-CPBA 
rather than using the purchased purity. 1H-NMR (400MHz, CDCl3) δ: 4.36 (2H, t, CH2), 2.76 (2H, 
m, CH2), 2.65 (2H, m, CH2), 2.59 (2H, m, CH2).
 13C-NMR (125MHz, CDCl3) δ: 205.14, 173.57, 
63.74, 44.86, 38.94, 28.31. 
Synthesis of Diallyl Ester 
To a round bottom flask equipped with a stir bar, was added 3-buten-1-ol (3.27g; 45.3 mmol; 1.0 
eq) and DCM (25mL; excess). A diluted solution of 4-pentenoyl chloride (5.37g; 45.3 mmol; 1.0 
eq) and DCM (25mL; excess) was created in an addition funnel. The 4-pentenoyl chloride solution 
was then added drop wise to the stirring reaction mixture over 30 minutes and the reaction was 
allowed to run for 3h until TLC indicated the reaction was complete. The excess solvent was then 
removed on the rotary evaporator to afford the crude product. The resulting crude liquid product 
was purified using flash chromatography to yield the pure clear liquid product. 1H-NMR (500MHz, 
CDCl3/TMS) δ 5.78 (2H, m, CH), 5.07 (4H, m, CH2), 4.12 (2H, t, CH2O), 2.38 (6H, m, 3CH2). 
13C-NMR (125MHz, CDCl3) δ 173.22, 136.89, 134.22, 117.38, 115.65, 63.61, 33.73, 33.28, 29.07. 
Synthesis of Glycidyl Ester Allyl 
To a round bottom flask equipped with a stir bar, was added the previously synthesized diallyl 
ester (2.90g; 18.8 mmol; 1.0 eq), m-CPBA (3.24g; 18.8 mmol; 1.0 eq), and DCM (53.66mL; 
5.4x10-2 g/mL). The oxidation reaction was then allowed to run for 48h. The crude product was 
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then vacuum filtered to remove the white precipitate before extracting the filtrate with saturated 
sodium bicarbonate to remove any unreacted m-CPBA. The excess DCM was then removed on 
the rotary evaporator to afford the clear crude liquid product. The resulting crude liquid product 
was purified on the Biotage column system to yield the pure clear liquid product. 1H-NMR 
(500MHz, CDCl3) δ 5.82 (1H, m, CH), 5.09 (2H, m, CH2), 4.41 (1H, dd, CH2), 3.93 (1H, q, CH2), 
3.21 (1H, sext, CH), 2.85 (1H, t, CH2), 2.65 (1H, q, CH2), 2.47 (2H, m, CH2), 2.40 (2H, m, CH2). 
13C-NMR (125MHz, CDCl3) δ 174.27, 138, 116.06, 66.23, 50.42, 45.13, 34.27, 29.96. 
General Procedure for the synthesis of VL/AVL/OPD copolymers. 
A 25mL and a 10mL round bottom flask were flame-dried under N2(g), along with a 50mL 3-neck 
round bottom flask equipped with a stir bar. In the 25mL round bottom flask, an 1.7M IAOH stock 
solution was formed using dry THF, while the 10mL round bottom flask was used to create a 3.7 
x 10-2M tin triflate stock solution, also using dry THF. Sn(OTf)2 (0.30mL; 8.83x10
-6 mmol; 
0.00035 eq) and IAOH (0.29mL; 3.33x10-4 mmol; 0.066 eq) were added to the reaction flask. The 
stock solutions were allowed to stir for 10 minutes before adding the δ-valerolactone (1.92g; 
19.2mmol; 3.0 eq), 2-oxepane-1,5-dione (0.82g; 6.0mmol; 1.0 eq), and the previously synthesized 
α-allyl-δ-valerolactone (0.90g; 6.40mmol; 1.0 eq). The reaction was then allowed to run for 24h 
at room temperature. After 24h the resulting viscous polymer product was precipitated into cold 
diethyl ether to afford the off-white particulate polymer product. The diethyl ether was decanted 
from the product, which was then transferred to a 6-dram vial, using ethyl acetate. Yield: 97% 1H-
NMR (400MHz, CDCl3) δ: 5.71 (1H, m, CH), 5.03 (2H, m, CH2), 4.34 (2H), 4.08 (10.79H), 3.67 
(1.04H), 2.52-2.86 (6.68H), 2.15-2.51 (13.22H), 1.67 (22.63H). 13C-NMR (100MHz, CDCl3) δ: 
135.33, 117.73, 69.64, 68.76, 64.11, 39.57, 35.71, 33.89, 30.05, 28.26, 24.36, 22.53, 21.61, 19.33.  
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General Procedure for the synthesis of GLY/AGE copolymers. 
A 25 mL round bottom flask, equipped with stir bar, was capped with a rubber septum and flame 
dried under nitrogen. Sn(OTf)2 (5.2mg; 12.48µmol; 0.4 eq) was then added to round bottom flask 
and the reaction vessel was then immediately purged with nitrogen again prior to the addition of 
IAOH (43.7mg 496µmol; 17.4 eq) via microsyringe. The initiator-catalyst mixture was then 
allowed to stir at room temperature for 30 minutes before lowering the reaction vessel into an ice 
water bath. After the reaction vessel had been cooled for 5 minutes, the AGE monomer (834mg; 
7.31mmol; 250 eq) was added drop wise to the stirring reaction. The GLY monomer (2.17g; 
29.2mmol; 1000eq) was added dropwise in 4 separate aliquots, allowing 5 minute breaks between 
each aliquot, to ensure the exothermic reaction did not overheat and decompose. After stirring was 
completely impeded (~14 hours) the crude reaction mixture was solubilized in a minimal amount 
of methanol and precipitated into vigorously stirring ethyl acetate. The precipitation solvent was 
allowed to settle before carefully decanting the ethyl acetate. The resulting GLY/AGE copolymer 
was solubilized in methanol, removed to a weighed 6-dram vial, and dried on the rotary evaporator 
then high vacuum pump to afford the translucent, viscous product. Yield 73.2% 1H-NMR 
(600MHz, MeOD) δ: 6.0-5.90 (m, –OCH2CHCH2), 5.37–5.17 (m, –OCH2CHCH2) .3.97-3.42 
(6H). 13C-NMR (150MHz, MeOD) δ: 136.31, 117.39, 81.37, 79.81, 75.12, 73.88, 72.01-72.94, 
70.42-71.17, 64.41, 62.53, 62.06, 27.99, 27.60. 
Synthesis of GLY/MLGEA Polymer (80/20) 
A 25 mL round bottom flask, equipped with a stir bar, was capped with a rubber septum and flame 
dried under nitrogen. Sn(OTf)2 (0.10g; 3.75x10
-6 mol; 0.00035 eq) and EtOH (0.10mL; 1.67x10-4 
mol; 0.066 eq) were added to the reaction flask. The initiator-catalyst mixture was then allowed to 
stir at room temperature for 30 minutes before lowering the reaction vessel into an ice water bath. 
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After the reaction vessel had been cooled for 5 minutes the previously synthesized mixed length 
glycidyl ester allyl (0.36g; 2.1 mmol; 1.0 eq) was added dropwise to the stirring mixture followed 
by the glycidol (0.64g; 8.6 mmol; 4.0 eq) monomer. After stirring was completely impeded (~14 
hours) the crude reaction mixture was solubilized in a minimal amount of methanol and 
precipitated into vigorously stirring ethyl acetate. The precipitation solvent was allowed to settle 
before carefully decanting the ethyl acetate. The resulting GLY/MLGEA copolymer was 
solubilized in methanol, removed to a weighed 6-dram vial, and dried on the rotary evaporator, 
then under high vacuum, to afford the translucent, viscous product. Yield: 633.7mg (63.37%). 1H-
NMR (600MHz, CDCl3) δ: 5.93 (1H), 5.27 (2.37H), 4.06-4.28 (2.91H) 3.26-3.98 (303.6H), 2.24-
2.63 (8.25H), 1.84 (2.57H), 1.65 (18.67H). 13C-NMR (150MHz, CDCl3) δ: 138.53, 72.90, 71.32, 
63.42, 61.52, 26.55. 
Nanoparticle formation through thiolene-click reactions using VL/OPD/AVL copolymers 
(450nm) 
To a round bottom flask equipped with a stir bar, was added the VL/OPD/AVL polymer (100.1mg; 
0.18mmol; 1 eq), 3,6-dioxa-1,8-octanedithiol (197.3mg; 1.08mmol; 6 eq), and dichloromethane 
(55.66mL; 3.24x10-3M). The flask was then fitted with a reflux condenser and lowered into an oil 
bath at 45°C to reflux for 12h. The resulting solution was then transferred to 10K dialysis tubing 
and dialyzed for 72h against dichloromethane to remove any unreacted starting material. The 
remaining product solution was then concentrated into a preweighed vial and stored in the 
refrigerator at 4°C. 1H-NMR (600MHz, CDCl3) δ: 5.71 (1H, m, CH), 5.03 (2H, m, CH2), 4.34 
(2H), 4.08 (10.79H), 3.67 (1.04H), 2.52-2.86 (6.68H), 2.15-2.51 (13.22H), 1.67 (22.63H). 13C-
NMR (150MHz, CDCl3) δ: 135.33, 117.73, 69.64, 68.76, 64.11, 39.57, 35.71, 33.89, 30.05, 28.26, 
24.36, 22.53, 21.61, 19.33. 
80 
 
Nanoparticle formation through thiolene-click reactions using GLY/AGE copolymers 
(50nm) 
To a round bottom flask equipped with a stir bar, was added the GLY/AGE polymer (111mg; 
1.79x10-1mmol; 2 eq), 3,6-dioxa-1,8-octanedithiol (16.35mg; 8.97x10-2mmol; 1 eq), and methanol 
(55.36mL; 3.24x10-3M). The flask was then fitted with a reflux condenser and lowered into an oil 
bath at 45°C to reflux for 12h. The resulting solution was then transferred to 10K dialysis tubing 
and dialyzed for 72h against methanol to remove any unreacted starting material. The remaining 
product solution was then concentrated into a preweighed vial and stored in the refrigerator at 4°C. 
1H-NMR (600MHz, CDCl3) δ: 6.0-5.90  (m, –OCH2CHCH2), 5.37–5.17 (m, –OCH2CHCH2) 
.3.97-3.42 (6H). 13C-NMR (150MHz, MeOD) δ: 136.31, 117.39, 81.37, 79.81, 75.12, 73.88, 
72.01-72.94, 70.42-71.17, 64.41, 62.53, 62.06, 27.99, 27.60. 
Temozolomide encapsulation into poly(ester) nanoparticles (NP-TMZ) 
A solution of poly(ester) nanoparticle (50.0 mg) and temozolomide (10.9 mg) in DMSO (0.150 
mL) was added dropwise to a vortexing solution of aqueous 1% d-α-tocopherol polyethyleneglycol 
(1000) succinate (Vit E-TPGS, 35.0 mL). As the nanoparticle solution was added, precipitation 
occured, and the resulting solution was centrifuged to remove the free drug from the encapsulated 
drug. In order to ensure all nonbound drug was removed, centrifugation was repeated three times 
with fresh water added after each run. The resulting product was freeze-dried to yield a white 
powder, and UV/Vis was employed to confirm temozolomide incorporation. 
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CHAPTER V 
 
MICRONSCALE NETWORKS THROUGH INKJET PRINTING 
Introduction 
 The potential for a drug delivery platform capable of combining the release of not only 
therapeutics but secondary delivery vehicles is highly advantageous1. Furthermore, to be able to 
tune the release of individual cargo, to accommodate different release rates for each therapeutic 
based on need, is a goal with exciting possibilities2. Research in this realm has had success in 
utilizing non-covalently bound polymer mixtures to co-deliver BMP2 along with a MEK inhibitor 
to promote enhanced bone growth in mice with neurofibromatosis type I, a gene mutation based 
disease which contributes to non-bone union after fractures in children3. However, much of the 
work currently being done requires incision and implantation of macro sized structures to facilitate 
the desired delivery of therapeutics.  
 In contrast, microparticle drug delivery platforms are well researched and of particular 
interest due to their ability to provide sustained release of loaded therapeutic cargo. Research in 
this area is well established and has shown that microparticles are well suited for treating a range 
of issues, including cancer4-6, diabetes7, and tuberculosis8. The synthesis routes known for the 
formation of such structures include techniques such as emulsion synthesis9-13, microfluidic 
devices14, 15, and spray drying16. While these methods are rather well known, they suffer from 
shape inconsistency and high polydispersity of particles. Furthermore, the large scale utilization 
of such particles is hindered by the price, reproducibility, and scalability of the formed particle 
species. In an effort to overcome the shortcomings of other microparticle synthesis techniques, 
two synthesis methods, lithography and ink jet printing, have been utilized to form well-defined 
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and reproducible microparticle structures. However, of these two, the print speed is slower, and 
the costs larger with lithography17. For these reasons, a fabrication method employing ink jet 
printing for the directed formation of well-defined and easily reproducible microparticles, which 
can be easily scaled to accommodate distribution, would quickly find a place as a viable drug 
delivery platform.  
 The integration of technology into the field of polymer research is leading to new and 
exciting possibilities, from automated polymerization machines to 3-D printing of tissue 
scaffolds18-21. One such instrument that has been employed is the piezoelectric ink jet printer, 
which has shown great potential for the formation of thin films as well as microparticle structures. 
This technique benefits greatly from its inherent ability to easily change the composition of the ink 
being used, affording an extremely tunable system with seemingly nonexistent limitations on the 
systems that can be formed17, 22-24. A fabrication method utilizing a commercially available 
instrument also means the scalability is not limited by reaction conditions but by the number of 
Hydrophilicity 
Network Density 
Microgel Size 
Network Softness 
Figure V-1: Desired hydrogel structures and tunable characteristics 
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printers that are operating at any given time. Finally, by tuning the instrument settings, such as 
nozzle size, accelerating voltage, and/or the voltage waveform used, one can easily direct the size 
of the formed particles (See Figure V-1).  
Despite these numerous advantages, research utilizing ink jet printing is far from 
expansive. Much of the work has focused on the optimization of waveforms for the purpose of 
particle size manipulation, with little intention for the particles to be removed from the surface 
onto which they were printed17. The only structures printed for the purpose of drug delivery 
employed the solvent evaporation method for particle formation and released their entire payload 
within the first six hours, far from to the type of sustained release that is often desirable in 
microparticle based systems. This fast release rate arose from a number of factors, including 
degradations and excessive swelling. 17, 22-24 
Within the realm of microparticle research, size becomes exceedingly important4, 14. The 
size of the microparticles formed often dictates the available options for utilization of the formed 
structures. With this in mind, it becomes desirable to be able to dictate the size of the particles 
formed through the manipulation a simple reaction condition, such as wt% of the polymer within 
the hydrogel printing solution. This method of change allows for the desired change in particle 
size without the necessity for major changes to the fabrication method. For this reason, a number 
of wt% solutions were employed to afford particles that ranged in size from 12.5µm down to 2µm. 
The ability to directly form particles of a desired size with such a minor perturbation to the printing 
solution is further validation of the robustness of this new fabrication method. 
 One method that has been utilized to decrease the swelling seen in other 
microparticle formulations is to covalently cross link the polymers of the system to form hydrogel 
architectures. There are a number of methods by which hydrogels can be formed, but the method 
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chosen must be compatible with the ink jet printing system. For this reason, the crosslinking 
chemistry should be able to occur at room temperature without the need for excessive perturbation 
of the printed structures. One such crosslinking mechanism is the thiolene click reaction, which 
employs a dithiol crosslinker and allyl functionalized polymers that, in the presence of a 
photoinitiator, can be irradiated with UV to facilitate the radical click reaction. When this reaction 
is performed, in a solution of proper concentration, it will lead to the formation of a hydrogel 
structure. Furthermore, the combination of the prepared hydrogel solution and the ink jet printing 
platform will lead to the formation of micron sized gel structures with very well defined sizes and 
low dispersity in size and/or shape.  
The research described here is focused on the formation of a delivery platform capable of 
co- and sequential-drug delivery with tunable characteristics, including hydrophilicity, size, 
network crosslinking density, and softness, on a size scale from 1-15µm, affording an injectable 
system with properties similar to their macroscale counterparts. 
Results and Discussion 
Synthesis of Polymer Building Blocks 
The desire to deliver a range of cargo with varied solubility and size necessitates the use of 
inherently different materials as the basis for the hydrogel structures. For this reason, two dialectic 
polymer species were chosen. First was a poly(carbonate) based polymer with allyl functionality 
which was synthesized as previously described (See Figure V-2). This species is highly 
hydrophobic and has shown the ability to form hydrogel structures with sustained linear release of 
small molecule drugs2. Furthermore, the enzymatic degradability of the carbonate moiety allows 
the body a mechanism for elimination of the poly(carbonate) backbone while the ester containing 
side arm can be targeted for hydrolytic cleavage. The second polymer chosen was a poly(glycidol) 
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based system with allyl functionality (See Figure V-3). This polymer was synthesized using the 
comonomers glycidol and allyl glycidyl ether, with Sn(OTf)2 catalyst, in a manner similar to 
information published previously. In contrast to the poly(carbonate), the poly(glycidol) system is 
completely water soluble, which allows for the investigation of water based gel formation, an 
advantageous characteristic when the delivery of biological cargo is desired. Also, the polyether 
backbone, and lack of hydrolytically cleavable esters in the side arms, presents a substantially 
different methodology for removal than is seen in the poly(carbonate) system. Both of these 
polymers present interesting characteristics that arise from their many differences, and for these 
reasons, three systems were chosen for investigation. The first system, consisting entirely of 
 
Figure V-2: Synthesis and 1H-NMR spectra for allyl poly(carbonate) 
 
 
 
 
 
 
 
Fig. XX:  
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poly(carbonate), represents a purely hydrophobic system. The second system is composed of a 
70/30 w% mixture of poly(carbonate)/poly(glycidol), which affords a system that is still mostly 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure V-3: Synthesis and 1H-NMR spectra for allyl poly(glycidol) 
 
 
 
 
 
 
 
 
 
 
 
Figure V-4: Polymer building blocks for hydrogel formation 
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hydrophobic by mass but will have some increased hydrophilicity and softness due to the 
poly(glycidol). The third system is comprised purely of poly(glycdidol) and represents a 
completely hydrophilic species.  
Formation of Macroscale Hydrogel Structures 
The use of thiolene click 
crosslinking was employed in 
order to form hydrogel samples 
utilizing the synthesized allyl 
functionalized polymers and 
dithiol species of varying 
molecular weight (See Figure V-
4). For samples 1 and 2, the 
polymers were solubilized in 
DMSO before the addition of 
DMPA (0.2eq per alkene). After 
thorough mixing with the tip of a 
needle, the dithiol crosslinker 
(0.5eq per alkene) was added via 
micro syringe and the hydrogel 
solution was again mixed with a 
needle to ensure complete 
solubilization and the formation 
of a homogenous solution (See Figure V-5). A similar procedure was followed for the formation 
 
Figure V-5: Three separate polymer mixtures were used 
for printing, and the influence of % m/v was investigated 
using the poly(carbonate)/poly(glycidol) system  
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of a mixed poly(carbonate)-poly(glycidol) hydrogel sample with both polymers being weighed 
together prior to solubilizaiotn in DMSO. As the use of a larger molecular weight dithiol was 
preferred for the poly(glycidol) based sample, and it was necessary to employ a water soluble 
photoinitiator (VA-044), the order for the addition of reagents was varied, with the solid dithiol 
(0.5eq per alkene) being added to a mixture of polymer in half the total desired amount of water. 
This solution was stirred, again with the tip of a needle, until the crosslinker was completely in 
solution before the addition of the second half of water containing the VA-044 (0.2eq per alkene) 
initiator (See Figure V-5).  
Once the hydrogel solutions had been completely solubilized, the samples were irradiated 
with long wave UV light (365nm) for five minutes to induce gelation. Upon completion of the gel 
formation, the samples were rinsed thoroughly with water, methanol, and methylene chloride to 
remove any unreacted starting materials and replace the reaction solvent with water so as to dry 
the samples via lyophilization. In order to determine the yields from the gelation, dry masses were 
compared to the total mass of the unreacted starting materials, with typical yields exceeding 90%.  
Determination of Limiting Hydrogel Concentration 
As the method being utilized in this research involves the ejection of a solution from a 
small printer head, the viscosity of the hydrogel solution plays a very important role. However, the 
mechanism of gel formation used has a threshold concentration below which hydrogel formation 
is not observed. For this reason it was imperative that a concentration be found that was as dilute 
as possible while still affording a hydrogel product. In order to determine this concentration, a 
dilution assay was performed on all three hydrogel samples wherein the dilution was increased 
linearly from 1:1 w/v to 1:15 w/v (polymer/solvent). As would be expected, the threshold 
concentration varied for each of the gel solutions with the addition of the branched poly(glycidol) 
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structure affording gelation at ever lower concentrations. The optimal dilution for samples 1, 2, 
and 3 was found to be 1:2, 1:4, and 1:10 respectively, and with this information it was hypothesized 
that there would be a decrease in size of the printed gels with the decrease in concentration as less 
polymer was present for gelation in each dot. 
Determination of Mechanical Properties of Model Hydrogel Structures 
Initial macroscale structures were formed using poly(carbonate) that was either doped with 
unfunctionalized poly(glycidol), which acted as a filler, or pure poly(carbonate). Furthermore, two 
separate dithiol crosslinkers were used to investigate the change this would have on the hydrogel’s 
properties. These systems were studied using unconfined compression to determine the mechanical 
properties of the structures, and yielded interesting results. The implantation of poly(glycidol) as 
a filler led to drastic increases in the deformability of the formed hydrogels, while the use of a 
longer crosslinker had a similar but less exaggerated effect. Subsequently, the compression 
modulus for the structures decreased with the increase in deformability. Despite this intriguing 
shift in hydrogel behavior, it was determined that the utilization of functionalized poly(glycidol) 
would be more advantageous as it affords a system that has hydrophilic and hydrophobic polymer 
chains covalently bound together, which should yield a system with enhanced delivery potential 
due to the ability to take advantage of favorable interactions between cargo and the hydrogel 
structure. 
Swelling Studies of Model Hydrogel Structures 
The ability of a gel to swell while in water is a characteristic that can directly influence the 
behavior of the gel system. Rapid swelling often leads to the rapid release of cargo as well as 
increased rates of degradation due to the increase in surface area. For these reasons it was important 
to find the swelling capability of each of the hydrogel solutions (See Figure V-6). As the amount 
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of poly(glycidol) was increased there 
was a distinct increase in swelling of 
the gels, which is to be expected due 
to the hydrophilic nature of the 
poly(glycidol) polymer. 
Furthermore, in the pure 
poly(carbonate) systems it was 
observed that the use of a longer crosslinker further enhanced the increase in swelling, a fact that 
can be explained by the high affinity PEG has for water. 
Fabrication and Characterization of Micronsized Hydrogel Structures 
The utilization of a Dimatix Materials printer was chosen in order to produce individual 
microgel spheres in a facile method with reproducible sizes. The hydrogel solutions were formed 
using the same methodology as was utilized for the bulk samples with the addition of a separate 
fluorescent dye for each hydrogel solution. Once the mixtures were in solution, they were carefully 
loaded into a Dimatix printer cartridge and the cartridge was placed within the Dimatix instrument. 
Initially, the substrates chosen for the printing process were glass slides. However, the relative 
surface area interaction for each dot afforded a situation in which the gels could not be easily 
removed from the glass surface. This issue was combated in two separate phases. For samples 1 
and 2, which are decisively more hydrophobic, the glass slides were coated with a sacrificial layer 
of poly(glycidol) by spin-coating a solution of poly(glycidol) in methanol (50/50 mass%). This 
method yielded surfaces that, once printed onto, could be easily removed with water to liberate the 
hydrogel structures. Unfortunately, this method could not work for the poly(glycidol) based system 
as the favorable hydrophilicities cause mixing of the gel solution and poly(glycidol) coating. For 
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this reason, a new and uniform surface was sought which could be used for all of the hydrogel 
systems. Chosen to fit this role was Teflon, which provides an excellent surface that proved useful 
for the overtly hydrophilic poly(glycidol) system. Once the printing substrates had been placed on 
the printing area, the Dimatix program was used to create a pattern which printed individual dots, 
with spacing of 100µm, in a continuous grid over the entire surface of the printing substrates. The 
ejection of the hydrogel solution from the printing cartridge was controlled by varying the voltages 
applied to the piezoelectric plate within the cartridge. A number of waveforms were tried before 
one was chosen which afforded the most consistent and uniform formation of drops17. Once the 
desired waveform had been determined, the hydrogel solution was printed onto the appropriate 
substrates. Upon completion, the substrate was carefully removed from the printing surface and 
irradiated with long wave UV (365nm) for 5 minutes in order to form the microgel spheres. The 
product gels could then be visualized using fluorescent microscopy. To investigate the printed gels 
on the substrate surface, a Nikon AZ100M microscope with a halogen lamp was utilized. This 
instrument allows for the determination of spatial resolution between the dots as well as 
confirmation of encapsulation of the fluorescent dye. Once it had been confirmed that the 
microdots were successfully printed onto the surface, water was used to rinse the gels from the 
surface into MakTek glass bottom culture dishes for investigation with confocal microscopy. The 
gels, now suspended in water, were thoroughly investigated using a Zeiss LSM Inverted Confocal 
Microscope to study their sizes, shapes, and, as the gels are relatively transparent, Z-stack images 
were obtained at progression rates of 0.05µm-0.25 µm. The data obtained from these cross 
sectional readings shows good integration of the fluorescent molecules throughout the hydrogel 
structure, meaning that any drug loaded into the system should be evenly distributed throughout 
the formed microgels. 
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Poly(carbonate) Particles 
 
 
 
 
Figure V-8: Fluorescent 
microscopy of printed and 
floating poly(carbonate) 
microgels 
Figure V-7: Formation of poly(carbonate) hydrogel 
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The first printing system investigated was a pure poly(carbonate) based ink primed with 
dithiol crosslinker, DMPA initiator, and Nile Red as a model hydrophobic drug (See Figure V-7). 
For this composition, poly(glycidol) coated slides were employed to give a hydrophilic surface for 
the hydrophobic hydrogel solution to be printed onto. The resulting printed particles were easily 
visualized using fluorescent microscopy, due to the incorporation of Nile Red, and showed good 
uniformity and spacing on the poly(glycidol) coated surface (See Figure V-8). Once washed from 
the surface and resuspended, the particles could be visualized using confocal microscopy, and the 
results were fascinating. Utilizing the facile new particle fabrication method, particles with an 
average size of 12.5µm were obtained. The size disparity among the printed particles was seen to 
be minimal and the Nile Red dye was observed to be distributed evenly throughout the particle 
structure, which suppirts the argument that any therapeutic loaded into the system should also 
exhibit this homogenous distribution. Furthermore, the particles exhibited good porosity, a 
characteristic that increases surface area and decreases overall particle mass. This characteristic is 
highly advantageous for delivery methods such as inhalation, where the low particle mass affords 
better aerosolization4. Also, the particle size of 12.5µm falls nicely in the size range of particles 
capable of accomplishing both good nasal cavity and throat distribution, as well as entry into the 
lower portions of the lungs for directed delivery of therapeutic cargo. 
Poly(carbonate)/Poly(glycidol) Particles  
The ability to form hydrogel networks with both hydrophobic and hydrophilic character 
expands the potential for cargo delivery and tunable release. In order to investigate this possibility, 
a hybrid system was formed using 70/30 m/m combination of poly(carbonate)/poly(glycidol) 
polymer chains. The hydrogel ink for this investigation was primed with dithiol crosslinker, 
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DMPA initiator, and coumarin 30 as a model hydrophobic drug. Since these gels are still mostly 
 
DMPA initiator, and coumarin 30 as a model hydrophobic drug (See Figure V-9). Since these gels 
are still mostly hydrophobic, the poly(glycidol) coated slides were used as a printing surface, and 
the printed particles were again visualized using fluorescent microscopy. Interestingly, when the 
 
Figure V-9: Formation of polycarbon te/poly(glycidol) hydrogel 
Figure V-10: Fluorescent microscopy of 
printed and floating poly(carbonate) 
/poly(glycidol) microgels 
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hydrogel products were rinsed from the slide for confocal investigation, it was observed the 
particles were smaller in size than those formed purely from poly(carbonate), with the average size 
of the products around 10µm, though the uniformity of the system was decreased (See Figure V-
10). However, these hybrid particles were seen to be much more mobile and able to bump into 
each other and continue moving without any perceived aggregation. This fact is very important 
when considering the utilization of these systems for intravenous delivery, where aggregation leads 
to potentially deadly side effects. The size of the particles formed is again well suited for inhalation 
and direct injection therapies, and the formation of these hybrid systems is a great representation 
of the potential of this method to form covalently bound hydrogel structures with tunable 
hydrophilicity.  
Poly(glycidol) Particles 
 The final printing composition investigated was pure poly(glycidol). In this case the solvent 
used was water, an exciting point that further expands the possible cargo. For this ink a larger 
crosslinker was used to allow for water solubility, and a water soluble photoinitiator, in this case 
VA-044, was employed. Finally, the use of a thiolated Cy2 dye served as a model hydrophilic drug 
and readily visible fluorophore. For this formulation the use of poly(glycidol) coated slides is not 
Figure V-11: Formation of poly(glycidol) hydrogel 
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possible due to mixing of the two hydrophilic systems, so Teflon sheets were utilized as a printing 
surface. The printed particles were visualized using fluorescent microscopy, and after gelation, 
were washed from the Teflon surface and studied with confocal microscopy. The resulting gel 
structures were much smaller at an average size of around 2µm. However, the particles maintained 
the high homogeneity seen in the larger structures as well as the nicely spherical morphology. 
Furthermore, the drastic decrease in size led to particle structures approaching the 1µm size range 
that is capable of utilization as a vaccine platform, and since the particles are entirely 
poly(glycidol) they are very soft, another desirous quality in vaccines.  
Control of Microgel Size: Influence of Mass/Volume Percent 
The ability to tune the hydrophilicity of the hydrogel system is advantageous, but it is also 
desirable to be able to direct the size of the particles that are being formed so that the system can 
 
Figure V-12: Fluorescent 
microscopy of printed and 
floating poly(glycidol) 
microgels 
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be optimized for various forms of delivery. It was hypothesized that a decrease in the weight 
percent of the polymer solution, thus decreasing the amount of polymer in each printed drop, would 
lead to a decrease in the size of the printed polymer structures. To investigate this proposition 
poly(carbonate)/poly(glycidol) hydrogel precursors were printed as before with the mass percent 
of the ink being decreased by 20%. The resulting particles looked similar upon printing, but once 
washed from the surface an interesting change was observed. The particles formed with the lower 
weight percent solution were decreased in size by almost the same amount as the decrease in 
weight percent, with particles an average size of around 7.75µm. The ability to tune the size of the 
printed hydrogels with such an easily manipulated parameter is an exciting discovery that opens 
the door to the formation of even more particle sizes than have been created thus far.  
 
 
 
Figure V-13: Fluorescent 
microscopy of printed and floating 
poly(carbonate) /poly(glycidol) 
microgels with lower %m/v 
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Utilization of AFM to Determine Mechanical Properties of Microparticles 
In order to determine if any change in the mechanical properties of the hydrogel structures 
occurs due to the small size of the printed microgel systems, an advanced atomic force microscopy 
technique was employed. In this type of measurement, an AFM cantilever with known spring 
constant is used to investigate the different gel systems on a silica surface. Since the spring constant 
of the cantilever is known, measurements can be directly correlated to the mechanical properties 
of the printed gel structures. 
Conclusion 
 The discovery of a method for the formation of highly controlled and monodisperse 
micron-sized particles, with a method that is exceptionally scalable, has been described. Though 
piezoelectric printing has been employed previously for polymer deposition, and there are methods 
available for the formation of microparticles, the marriage of particle synthesis with piezoelectric 
printing is truly novel. These systems are tunable, not only through the incorporation of variable 
polymer structures, but also with the utilization of varied solution concentration. This work 
represents the first steps along a path towards the formation of reproducible and scalable 
microparticle formation capable of incorporating a seemingly endless list of therapeutic cargo. 
Experimental 
Materials 
All reaction solvents used were HPLC quality and purchased form Sigma Aldrich. All NMR 
solvents were purchased from Cambridge Isotope Laboratories, Inc. and used without further 
purification. 2,2-bis(hydroxymethyl) propionic acid (Bis-HPA), Amberlyst® 15 Hydrogen Form 
(A-15), allyl glycidyl ether (AGE), anhydrous Iso-Amyl alcohol (IAOH), 3,6-Dioxa-1,8-
octanedithiol, nile red, coumarin 30, and 2,2-dimethoxy-2-phenylacetophenone (DMPA) were 
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purchased from Sigma Aldrich and used without further purification. Glycdiol (GLY) was 
purchased from Sigma Aldrich and vacuum distilled prior to use. Thiol PEG Thiol (HS-PEG-SH) 
was purchased from Nanocs and used without further purification. 2,2'-Azobis[2-(2-imidazolin-2-
yl)propane]dihydrochloride (VA-044) was purchased from Wako chemicals and used without 
further purification. Tin(II) trifluoromethane sulfonate (Sn(OTf)2) was purchased from Strem 
Chemicals Inc. and used without further purification. Teflon sheets were obtained from ePlastics. 
Dialysis membranes (Spectra/Por® 7, molecular weight cut-off (MWCO): 1,000 Da) were 
obtained from Spectrum Laboratories, Inc. 5-methyl-5-allyloxycarbonyl-1,3-dioxane-2-one 
(MAC), and 5-methyl-5-ethyloxycarbonyl-1,3-dioxane-2-one (MEC) were synthesized according 
to the literature and recrystallized prior to use. MEC/MAC copolymers were synthesized according 
to work previously published and dialyzed before use.  
Characterization 
1H NMR and 13C NMR spectra were obtained from a Bruker AC400 Fourier Transform 
Spectrometer, with CDCl3/TMS as the solvent. Gel permeation chromatography (GPC) was 
carried out with a Waters chromatograph system equipped with a Waters 2414 refractive index 
detector, a Waters 2481 dual λ absorbance detector, a Waters 1525 binary HPLC pump, and four 
5 mm Waters columns (300 mm x 7.7 mm), connected in series with increasing pore size (100, 
1000, 100,000 and 1,000,000 Ǻ respectively). All runs were performed with dimethylformamide 
(DMF) or tetrahydrofuran (THF) as the eluent at a flow rate of 1 mL/min.  
General Procedure for the synthesis of GLY, AGE copolymers. 
A 25 mL round bottom flask, equipped with stir bar, was capped with a rubber septum and flame 
dried under nitrogen. Sn(OTf)2 (5.2mg; 12.48µmol; 0.4 eq) was then added to round bottom flask 
and the reaction vessel was then immediately purged with nitrogen again prior to the addition of 
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IAOH (43.7mg 495.6µmol; 17.4 eq) via microsyringe. The initiator-catalyst mixture was then 
allowed to stir at room temperature for 30 minutes before lowering the reaction vessel into an ice 
water bath. After the reaction vessel had been cooled for 5 minutes the AGE monomer (834mg; 
7.31mmol; 250 eq) was added dropwise to the stirring reaction. The GLY monomer (2.17g; 
29.24mmol; 1000eq) was added dropwise in 4 separate aliquots, allowing 5 minute breaks between 
each aliquot, to ensure the exothermic reaction did not overheat and decompose. After stirring was 
completely impeded (~14 hours) the crude reaction mixture was solubilized in a minimal amount 
of methanol and precipitated into vigorously stirring ethyl acetate. The precipitation solvent was 
allowed to settle before carefully decanting the ethyl acetate. The resulting GLY/AGE copolymer 
was solubilized in methanol, removed to a weighed 6-dram vial, and dried on the rotary evaporator, 
then under high vacuum, to afford the translucent, viscous product. 1H-NMR (600MHz, MeOD) 
δ:6.0-5.90  (m, –OCH2CHCH2), 5.37–5.17 (m, –OCH2CHCH2) .3.97-3.42 (6H). 13C-NMR 
(150MHz, MeOD) δ: 136.31, 117.39, 81.37, 79.81, 75.12, 73.88, 72.01-72.94, 70.42-71.17, 64.41, 
62.53, 62.06, 27.99, 27.60. 
Coating of Glass Substrates with Poly(glycidol) 
The ability to remove the printed hydrogels from the chosen substrate proved difficult. Due to the 
small size of the printed particles, favorable surface interactions between the gels and surface 
hindered the facile removal of the products. For this reason it was decided that the glass substrates 
would be coated with poly(glycidol) which afforded a hydrophilic surface that could be easily 
removed by simple water rinsing. This method also yields a surface with favorable 
hydrophilic/hydrophobic interactions between the poly(glycidol) and poly(methyl-ethyl-co-
methyl-allyl-carbonate) printing solution, which allows for an increase in the printing density on 
each surface as the printed poly(carbonate) polymer remains static on the hydrophilic surface. 
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General Procedure for Formation of Hydrogel Printing Solution in DMSO (Samples 1 and 
2) 
3,6-Dioxa-1,8-octanedithiol (0.5eq. per alkene) was added via micro syringe to a solution of the 
allyl functionalized polymer (100mg total mass) and 2,2-dimethoxy-2-phenylacetophenone 
(DMPA, 0.2eq. per alkene) in DMSO with the desired fluorescent dye. After thorough mixing with 
the tip of a syringe, and allowing to rest to ensure no air bubbles were present, the prepared printing 
solution was loaded into a Dimatix printing cartridge using a blunt tip needle. The printing 
cartridge was then loaded into the Dimatix materials printer. Printing substrates were then placed 
on the printing platen before printing was begun. After printing of the particles, the printed 
microdots were irradiated with long wave UV light (365nm) for 5 minutes to induce gelation. After 
gelation had occurred the substrates were imaged using fluorescent microscopy to visualize the 
printed region before being rinsed with water to dissolve the poly(glycidol) and liberate the 
microdots from the surface. The microdots were then imaged using confocal microscopy to 
investigate their sizes. 
General Procedure for Formation of Hydrogel Printing Solution in Water (Sample 3) 
HS-PEG-SH (0.5eq. per alkene) was added to a solution of the allyl functionalized polymer 
(100mg total mass) in water and mixed well with the tip of a needle until completely solubilized 
in a 1-dram vial. 2,2'-Azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride (VA-044, 0.2eq. per 
alkene) was then added to the printing solution along with the thiolated fluorescent dye. The 
solution was again mixed with the tip of a needle and allowed to rest to ensure no air bubbles were 
present before the prepared printing solution was loaded into a Dimatix printing cartridge using a 
blunt tip needle. The printing cartridge was then loaded into the Dimatix materials printer. Teflon 
strips were then placed on the printing platen before printing was begun. After printing of the 
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particles the printed microdots were irradiated with long wave UV light (365nm) for 5 minutes to 
induce gelation. After gelation had occurred, the substrates were imaged using fluorescent 
microscopy to visualize the printed region before being rinsed with water to liberate the microdots 
from the surface. The microdots were then imaged using confocal microscopy to investigate their 
sizes. 
General Procedure for Formation of Bulk Hydrogel Samples in DMSO (Samples 1 and 2) 
3,6-Dioxa-1,8-octanedithiol (0.5eq. per alkene) was added via micro syringe to a solution of the 
allyl functionalized polymer (100mg total mass) and 2,2-dimethoxy-2-phenylacetophenone 
(DMPA, 0.2eq. per alkene) in DMSO with the desired fluorescent dye in a 1-dram vial (See Figure 
V-14). After thorough mixing with the tip of a syringe, and allowing the solution to rest to ensure 
no air bubbles were present, the solution was irradiated with long wave UV light (365nm) for 5 
minutes to induce gelation. The gels were then rinsed sequentially with 3mL aliquots of water, 
methanol, methylene chloride, methanol and finally water again to remove any unreacted starting 
materials. The gels were then submerged in water and frozen before being lyophilized to afford 
the dry hydrogel product.  
General Procedure for Formation of Bulk Hydrogel Samples in Water (Sample 3) 
HS-PEG-SH (0.5eq. per alkene) was added to a solution of the allyl functionalized polymer 
(100mg total mass) in water and mixed well with the tip of a needle until completely solubilized 
in a 1-dram vial. 2,2'-Azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride (VA-044, 0.2eq. per 
alkene) was then added to the printing solution along with the thiolated fluorescent dye (See Figure 
V-14). The solution was again mixed with the tip of a needle and allowed to rest to ensure no air 
bubbles were present before being irradiated with long wave UV light (365nm) for 5 minutes to 
induce gelation. The gels were then rinsed sequentially with 3mL aliquots of water, methanol, 
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ethylene chloride, methanol and finally water again to remove any unreacted starting materials. 
The gels were then submerged in water and frozen before being lyophilized to afford the dry 
hydrogel product. 
Sample Poly(carbonate) Poly(glycidol) Solvent Fluorescent Dye 
1 100mg 0mg 200µL Nile Red 
2 70mg 30mg 400µL Coumarin 20 
2b 70mg 30mg 500µL Coumarin 20 
3 0mg 100mg 1000µL Thiolated Dye 
Fluoroscopy Measurements. 
Fluoroscopy images were obtained using two separate microscopes. For the printed samples still 
on the substrates, a Nikon AZ 100 M microscope with halogen lamp was used to image the freshly 
printed gels before and after gelation. Once the gels had been removed from the substrates, and 
suspended in water, the individual gels were imaged using a Zeiss LSM 510 Inverted Confocal 
Microscope. 
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